https://pharmadispatch.com/news/boehringer-ingelheims-auckland-office-leads-sustainability-in-nz-pharma-sector 2025-01-11T08:35:01+11:00 https://pharmadispatch.com/news/attitudes-may-have-evolved-but-the-framework-they-created-remains-virtually-unchanged 2025-01-13T11:30:01+11:00 https://pharmadispatch.com/news/delays-were-the-intended-outcome-not-an-unintended-consequence 2025-01-14T06:48:01+11:00 https://pharmadispatch.com/news/do-patients-do-not-live-their-condition-in-aggregated-economic-models 2025-01-15T09:25:01+11:00 https://pharmadispatch.com/news/could-this-systems-nobility-recognise-a-new-idea-even-if-they-saw-it 2025-01-16T08:04:01+11:00 https://pharmadispatch.com/news/make-the-institution-and-its-nobility-work-for-patients-not-the-government 2025-01-16T13:18:01+11:00 https://pharmadispatch.com/news/new-leadership-for-boehringer-ingelheim-as-the-company-recognised-as-top-employer 2025-01-20T14:00:01+11:00 https://pharmadispatch.com/news/christopher-luxon-replaces-health-minister-in-push-for-faster-progress-on-change 2025-01-20T14:00:01+11:00 https://pharmadispatch.com/news/this-is-a-world-leading-approach-to-reduce-the-impact-of-rsv-on-babies 2025-01-20T16:32:01+11:00 https://pharmadispatch.com/news/stoking-good-antibodies-key-to-reducing-serious-bee-venom-allergic-reactions 2025-01-20T20:54:01+11:00 https://pharmadispatch.com/news/takeda-named-global-top-employer-for-eighth-consecutive-year 2025-01-20T23:19:01+11:00 https://pharmadispatch.com/news/us-issues-list-of-next-15-medicines-to-face-price-negotiation-power 2025-01-21T00:47:01+11:00 https://pharmadispatch.com/news/australian-company-vaxxas-named-stage-winner-of-us-prize-to-advance-vaccine-patches 2025-01-21T01:26:01+11:00 https://pharmadispatch.com/news/biocina-and-novacina-merger-aims-to-bolster-the-global-cdmo-industry 2025-01-21T15:39:01+11:00 https://pharmadispatch.com/news/fighting-the-technical-endorses-the-framework-that-makes-patients-servile-to-the-states-economic 2025-01-21T19:29:01+11:00 https://pharmadispatch.com/news/ltr-pharma-signs-national-pharmacy-distribution-agreement-with-symbion 2025-01-22T21:01:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-says-all-subjects-now-enrolled-in-key-arm-protect-clinical-trial 2025-01-22T21:16:01+11:00 https://pharmadispatch.com/news/emyria-announces-key-leadership-changes 2025-01-22T21:43:01+11:00 https://pharmadispatch.com/news/immutep-completes-patient-enrolment-for-eftisarc-neo-phase-2-trial 2025-01-22T22:21:01+11:00 https://pharmadispatch.com/news/pharmac-encourages-input-on-on-cancer-and-adhd-medicines-funding-proposal 2025-01-23T02:04:01+11:00 https://pharmadispatch.com/news/could-preventive-treatments-support-ongoing-fight-against-covid 2025-01-23T15:58:01+11:00 https://pharmadispatch.com/news/cabinet-documents-reveal-decades-old-focus-on-faster-pbs-listings 2025-01-24T14:00:01+11:00 https://pharmadispatch.com/news/cepi-backing-for-vaxxas-to-advance-needle-free-thermostable-mrna-vaccines 2025-01-23T22:51:01+11:00 https://pharmadispatch.com/news/no-probity-advisor-but-what-about-a-form-of-confidentiality-deed 2025-01-24T14:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-24-january 2025-01-24T23:44:01+11:00 https://pharmadispatch.com/news/tga-approves-csls-locally-discovered-and-developed-biologic 2025-01-28T14:00:01+11:00 https://pharmadispatch.com/news/is-the-government-willing-to-consider-elevating-patient-rights-at-the-expense-of-its-economic-in 2025-01-28T14:52:01+11:00 https://pharmadispatch.com/news/pharmacy-congratulates-recipients-of-australia-day-honours 2025-01-28T14:00:01+11:00 https://pharmadispatch.com/news/idt-updates-investors-expecting-a-significant-spike-in-revenue 2025-01-28T22:42:01+11:00 https://pharmadispatch.com/news/medicines-australia-wants-progress-on-immediate-impact-recommendations 2025-01-28T23:13:01+11:00 https://pharmadispatch.com/news/medicines-australia-is-trapped-arguing-for-changes-that-wont-make-a-positive-difference-1 2025-01-28T23:34:01+11:00 https://pharmadispatch.com/news/chemist-warehouse-reports-strong-sales-and-earnings-growth-with-merger-to-progress 2025-01-29T01:29:01+11:00 https://pharmadispatch.com/news/tga-approves-apellis-therapy-for-a-form-of-age-related-macular-degeneration 2025-01-28T14:00:01+11:00 https://pharmadispatch.com/news/qbiotics-strengthens-medical-leadership-with-two-senior-appointments 2025-01-29T04:13:01+11:00 https://pharmadispatch.com/news/presidential-nominee-denies-calling-for-seizure-of-pharmaceutical-patents 2025-01-30T14:00:01+11:00 https://pharmadispatch.com/news/gps-call-on-nsw-government-to-fund-free-meningococcal-b-vaccine 2025-01-30T14:00:01+11:00 https://pharmadispatch.com/news/new-zealands-pharmac-reconsiders-proposed-move-to-single-oestradiol-patch-brand 2025-01-30T14:00:01+11:00 https://pharmadispatch.com/news/teams-lining-up-again-for-the-rare-cancers-australia-kosi-challenge 2025-01-31T14:00:01+11:00 https://pharmadispatch.com/news/trump-backs-price-negotiation-power-as-health-nominee-faces-contentious-hearing 2025-01-31T14:00:01+11:00 https://pharmadispatch.com/news/sigma-chemist-warehouse-merger-set-to-proceed-following-shareholder-backing 2025-01-31T14:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-week-in-review 2025-01-31T23:01:01+11:00 https://pharmadispatch.com/news/patients-have-waited-and-in-the-health-ministers-own-words-died-wairing-for-this-potemkin-villag 2025-02-03T14:00:01+11:00 https://pharmadispatch.com/news/payment-model-took-four-submissions-and-almost-two-years-to-negotiate 2025-02-03T14:00:01+11:00 https://pharmadispatch.com/news/pbac-delivers-recommendations-for-mental-health-and-paediatric-immune-conditions 2025-02-03T14:00:01+11:00 https://pharmadispatch.com/news/mark-butler-confirms-new-listing-for-rare-form-of-lung-cancer 2025-02-03T14:00:01+11:00 https://pharmadispatch.com/news/how-is-it-fair-that-patients-have-no-rights-in-this-system-of-health-technology-assessment 2025-02-04T14:00:01+11:00 https://pharmadispatch.com/news/pharmac-tables-proposal-to-fund-a-new-oral-contraceptive 2025-02-04T14:00:01+11:00 https://pharmadispatch.com/news/for-many-people-living-with-cancer-the-journey-is-complex-and-fraught-with-difficulties 2025-02-04T14:00:01+11:00 https://pharmadispatch.com/news/omico-calls-for-major-government-industry-support-of-fundamental-change-in-cancer-treatment 2025-02-05T14:00:01+11:00 https://pharmadispatch.com/news/the-mindset-is-that-equitable-access-can-only-be-achieved-by-denying-everyone-on-the-same-basis 2025-02-05T14:00:01+11:00 https://pharmadispatch.com/news/baxter-kidney-care-is-now-vantive-as-a-standalone-organ-therapy-company 2025-02-05T14:00:01+11:00 https://pharmadispatch.com/news/one-believes-things-because-one-has-been-conditioned-to-believe-them 2025-02-06T14:07:01+11:00 https://pharmadispatch.com/news/rfk-jr-on-the-cusp-of-securing-his-nomination-to-lead-us-health-department 2025-02-06T14:00:01+11:00 https://pharmadispatch.com/news/advancell-successfully-completes-an-oversubscribed-series-c-financing 2025-02-06T16:17:01+11:00 https://pharmadispatch.com/news/in-an-optimal-equitable-system-access-to-evidence-based-cost-effective-genomics-guided-medicines 2025-02-07T14:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-7-february 2025-02-07T04:43:01+11:00 https://pharmadispatch.com/news/gsk-out-to-an-early-lead-in-rare-cancers-australia-kosi-challenge-pharma-cup 2025-02-07T14:02:01+11:00 https://pharmadispatch.com/news/unfortunately-there-remain-significant-gaps-in-knowledge-among-healthcare-professionals-when-it- 2025-02-10T14:00:01+11:00 https://pharmadispatch.com/news/sigma-upgrades-guidance-as-it-prepares-for-chemist-warehouse-merger 2025-02-10T14:00:01+11:00 https://pharmadispatch.com/news/community-welcomes-new-womens-health-initiative 2025-02-09T21:37:01+11:00 https://pharmadispatch.com/news/historical-change-on-pharmacy-prescribing-could-be-a-sign-of-more-to-come 2025-02-10T14:00:01+11:00 https://pharmadispatch.com/news/victorian-official-appointed-to-hta-review-implementation-advisory-group 2025-02-10T13:00:01+11:00 https://pharmadispatch.com/news/proponents-of-meaningful-hta-reform-might-consider-pharmacy-prescribing-as-a-case-study 2025-02-11T14:00:01+11:00 https://pharmadispatch.com/news/national-womens-health-initiatives-a-significant-step-forward-in-improving-access-to-care 2025-02-11T04:09:01+11:00 https://pharmadispatch.com/news/new-omico-podcast-aims-to-help-people-navigate-precision-oncology-and-genomic-innovation 2025-02-11T14:00:01+11:00 https://pharmadispatch.com/news/immunoglobulin-sales-drives-a-strong-first-half-for-csl-but-lower-immunisation-rates-hit-seqirus 2025-02-11T21:43:01+11:00 https://pharmadispatch.com/news/advancell-enters-strategic-collaboration-with-lilly-to-advance-novel-targeted-alpha-therapies 2025-02-12T01:42:01+11:00 https://pharmadispatch.com/news/sandoz-summit-promotes-reform-to-boost-the-use-of-biosimilars 2025-02-12T01:44:01+11:00 https://pharmadispatch.com/news/merck-adds-experienced-industry-executive-to-leadership-team 2025-02-12T02:26:01+11:00 https://pharmadispatch.com/news/specialised-therapeutics-announces-thai-approval-of-breast-cancer-therapy 2025-02-12T14:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-australia-says-election-it-the-chance-to-end-the-cancer-lottery 2025-02-12T14:00:01+11:00 https://pharmadispatch.com/news/immunoglobulin-sales-drives-a-strong-first-half-for-csl-but-lower-immunisation-rates-hit-seqirus 2025-02-12T16:59:01+11:00 https://pharmadispatch.com/news/uk-private-health-insurer-to-cover-weight-loss-therapies 2025-02-12T23:17:01+11:00 https://pharmadispatch.com/news/sigma-and-chemist-warehouse-complete-merger-to-create-pbs-giant 2025-02-12T14:00:01+11:00 https://pharmadispatch.com/news/australian-whooping-cough-cases-still-rising-after-record-year 2025-02-13T16:00:01+11:00 https://pharmadispatch.com/news/the-institution-defends-itself-by-effectively-arguing-that-deaths-are-a-necessary-consequence 2025-02-14T15:00:01+11:00 https://pharmadispatch.com/news/research-grants-on-patient-informed-decision-making-but-patients-need-not-apply 2025-02-14T14:02:01+11:00 https://pharmadispatch.com/news/merck-team-gathers-in-sydney-aiming-to-spark-discovery-and-elevate-humanity 2025-02-14T16:02:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-14-february 2025-02-15T00:29:01+11:00 https://pharmadispatch.com/news/the-confusing-public-debate-might-be-more-of-a-risk-to-public-confidence-in-genetic-testing 2025-02-17T08:00:01+11:00 https://pharmadispatch.com/news/industry-silence-revealing-as-new-presidential-order-targets-medicines-use 2025-02-17T08:00:01+11:00 https://pharmadispatch.com/news/we-rarely-have-feedback-and-more-often-than-not-the-process-doesnt-necessarily-result-in-better- 2025-02-17T08:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-soars-to-the-lead-in-kosi-challenge-pharma-cup 2025-02-17T06:33:01+11:00 https://pharmadispatch.com/news/pharmacy-renews-cost-of-living-campaign-with-60-day-quantities-still-flatlining 2025-02-18T00:38:01+11:00 https://pharmadispatch.com/news/hmri-partners-with-novartis-to-supercharge-heart-health-impact 2025-02-18T10:00:01+11:00 https://pharmadispatch.com/news/australian-company-axelia-oncology-announces-supply-agreement-for-pbs-listed-cancer-medicines 2025-02-18T02:08:01+11:00 https://pharmadispatch.com/news/australia-isnt-ready-for-the-next-cardiac-epidemic-warns-landmark-heart-valve-disease-report 2025-02-18T02:19:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-to-raise-up-to-146-million 2025-02-18T02:53:01+11:00 https://pharmadispatch.com/news/its-a-good-idea-that-will-need-to-overcome-a-institutional-mindset-to-progress 2025-02-20T05:00:01+11:00 https://pharmadispatch.com/news/pfizer-teams-up-with-heart-of-australia-to-expand-access-to-gp-education 2025-02-19T05:52:01+11:00 https://pharmadispatch.com/news/pharmx-technologies-partners-with-toniq-to-expand-pharmacy-solutions-in-new-zealand 2025-02-19T06:13:01+11:00 https://pharmadispatch.com/news/trump-suspends-law-that-fundamentally-changed-the-industrys-approach-to-public-affairs 2025-02-19T06:19:01+11:00 https://pharmadispatch.com/news/syntaras-topical-anti-fibrotic-drug-leads-to-significant-normalisation-of-skin-in-established-sc 2025-02-19T06:42:01+11:00 https://pharmadispatch.com/news/fda-grants-fast-track-designation-for-neurens-nnz-2591-in-pitt-hopkins-syndrome 2025-02-20T00:47:01+11:00 https://pharmadispatch.com/news/gbma-promotes-prescribing-shake-up-to-widen-access-and-deliver-savings 2025-02-20T01:40:01+11:00 https://pharmadispatch.com/news/montu-announces-two-new-appointments-to-leadership-team 2025-02-20T02:09:01+11:00 https://pharmadispatch.com/news/pharmaceuticals-the-latest-trump-target-for-tariffs 2025-02-20T05:00:01+11:00 https://pharmadispatch.com/news/idt-delivers-strong-first-half-performance-following-strategic-pivot 2025-02-20T02:59:01+11:00 https://pharmadispatch.com/news/significant-gift-new-academy-for-health-leadership-at-university-of-melbourne 2025-02-21T14:00:01+11:00 https://pharmadispatch.com/news/first-and-only-treatment-for-chronic-hypoparathyroidism-approved-in-australia 2025-02-21T14:00:01+11:00 https://pharmadispatch.com/news/psa-members-endorse-acquisition-of-the-australasian-college-of-pharmacy 2025-02-21T14:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-maintains-its-lead-as-other-teams-start-to-build 2025-02-21T14:00:01+11:00 https://pharmadispatch.com/news/ovarian-cancer-australia-says-new-report-highlights-the-need-for-action 2025-02-24T14:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-21-february 2025-02-22T01:43:01+11:00 https://pharmadispatch.com/news/high-profile-australians-expose-the-painful-reality-of-shingles-in-awareness-week 2025-02-24T14:00:01+11:00 https://pharmadispatch.com/news/msd-australia-receives-certification-as-a-family-friendly-workplace 2025-02-24T14:00:01+11:00 https://pharmadispatch.com/news/fix-the-language-accept-the-political-discomfort-it-will-cause-or-forget-about-meaningful-change 2025-02-24T14:00:01+11:00 https://pharmadispatch.com/news/abbvie-appoints-former-bayer-executive-to-lead-market-access-in-australia-and-nz 2025-02-24T14:00:01+11:00 https://pharmadispatch.com/news/neuren-receives-rare-paediatric-disease-designation-from-the-us-fda 2025-02-24T21:33:01+11:00 https://pharmadispatch.com/news/new-zealand-medtech-start-up-avasa-hits-milestone-in-development-of-worlds-first-arterial-couple 2025-02-24T21:40:01+11:00 https://pharmadispatch.com/news/adpha-welcomes-commitment-to-expand-access-to-bulk-billing-incentive 2025-02-24T23:49:01+11:00 https://pharmadispatch.com/news/orthocell-submits-for-remplir-regulatory-approval-in-thailand 2025-02-25T00:00:01+11:00 https://pharmadispatch.com/news/novartis-joins-legal-action-against-unapproved-copy-of-radioligand-therapy 2025-02-25T14:00:01+11:00 https://pharmadispatch.com/news/election-could-be-the-the-circuit-breaker-opportunity-to-recharge-reform 2025-02-25T23:48:01+11:00 https://pharmadispatch.com/news/new-whitepaper-reveals-strategies-to-manage-salary-trends-revealed-in-report 2025-02-26T02:58:01+11:00 https://pharmadispatch.com/news/health-department-to-front-senate-estimates-for-final-pre-election-hearing 2025-02-26T14:00:01+11:00 https://pharmadispatch.com/news/the-george-institute-welcomes-new-international-push-to-raise-the-bar-in-migraine 2025-02-26T14:00:01+11:00 https://pharmadispatch.com/news/us-fda-approves-elate-ocular-phase-3-clinical-trial-protocol 2025-02-26T21:04:01+11:00 https://pharmadispatch.com/news/mtpconnect-refreshes-board-with-new-appointment-and-retirement 2025-02-26T21:16:01+11:00 https://pharmadispatch.com/news/us-biotech-industry-welcomes-proposed-change-to-price-negotiation-power 2025-02-27T14:00:01+11:00 https://pharmadispatch.com/news/arovella-says-with-placement-it-is-now-fully-funded-to-complete-phase-1-clinical-trial 2025-02-26T22:02:01+11:00 https://pharmadispatch.com/news/us-fda-accepts-application-for-telixs-zircaix-and-grants-priority-review 2025-02-26T22:18:01+11:00 https://pharmadispatch.com/news/companies-to-blame-for-not-highlighting-quality-of-life-benefits 2025-02-26T23:13:01+11:00 https://pharmadispatch.com/news/hta-go-slow-on-newborn-screening-leaves-parents-waiting-and-waiting 2025-02-27T14:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-welcomes-future-funding-for-game-changing-cancer-service 2025-02-27T14:00:01+11:00 https://pharmadispatch.com/news/argenx-secures-tga-approval-of-precision-therapy-for-rare-disease 2025-02-28T14:00:01+11:00 https://pharmadispatch.com/news/the-cell-and-gene-catalyst-mobilises-71-leaders-to-accelerate-industry-growth 2025-02-28T14:00:01+11:00 https://pharmadispatch.com/news/health-department-appoints-consultant-to-support-hta-review-implementation-group 2025-02-28T14:00:01+11:00 https://pharmadispatch.com/news/take-the-right-learning-from-a-situation-that-was-mostly-about-ministerial-intervention 2025-02-28T15:00:01+11:00 https://pharmadispatch.com/news/companies-building-their-kosi-challenge-totals-with-two-weeks-to-go 2025-02-28T14:00:01+11:00 https://pharmadispatch.com/news/abbvie-welcomes-expanded-pbs-listing-for-severe-psoriatic-arthritis 2025-03-03T14:00:01+11:00 https://pharmadispatch.com/news/first-oral-contraceptive-listed-on-the-pbs-in-over-30-years 2025-03-02T20:58:01+11:00 https://pharmadispatch.com/news/tga-approves-first-biological-therapy-for-serious-respiratory-condition 2025-03-03T14:00:01+11:00 https://pharmadispatch.com/news/the-door-is-finally-ajar-to-initiate-some-much-needed-ceo-led-reforms-at-our-drug-buying-agency 2025-03-03T14:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-2-march 2025-03-03T03:40:01+11:00 https://pharmadispatch.com/news/australian-startup-launches-the-worlds-first-commercial-biological-computer 2025-03-03T20:44:01+11:00 https://pharmadispatch.com/news/sandoz-backs-australian-medicinal-cannabis-company-in-ten-year-agreement 2025-03-03T21:30:01+11:00 https://pharmadispatch.com/news/astellas-welcomes-tga-approval-of-cancer-combination-as-first-line-treatment 2025-03-04T14:00:01+11:00 https://pharmadispatch.com/news/is-personalised-gene-therapy-ready-for-prime-time 2025-03-04T14:00:01+11:00 https://pharmadispatch.com/news/csl-seqirus-secures-australia-nz-rights-to-commercialise-cholesterol-lowering-therapy 2025-03-04T14:00:01+11:00 https://pharmadispatch.com/news/biogen-and-eisai-working-on-next-steps-after-tga-confirms-non-approval-of-alzheimers-therapy 2025-03-04T14:00:01+11:00 https://pharmadispatch.com/news/researchers-disappointed-over-non-approval-of-alzheimers-treatment 2025-03-05T14:00:01+11:00 https://pharmadispatch.com/news/ministers-diary-reveals-no-meetings-on-deferral-controversy-and-this-might-be-why 2025-03-05T14:00:01+11:00 https://pharmadispatch.com/news/getting-back-to-the-original-question-is-personalised-gene-therapy-ready-for-prime-time 2025-03-05T16:00:01+11:00 https://pharmadispatch.com/news/pharma-cup-total-raises-towards-200000-with-ten-days-to-go 2025-03-05T04:41:01+11:00 https://pharmadispatch.com/news/new-data-supports-effective-delivery-of-dna-based-vaccines-using-patch 2025-03-05T20:41:01+11:00 https://pharmadispatch.com/news/government-partners-with-baxter-to-increase-local-production-of-iv-fluids 2025-03-06T14:00:01+11:00 https://pharmadispatch.com/news/new-report-calls-for-regulatory-enforcement-and-funding-to-secure-nuclear-medicine-potential 2025-03-06T14:00:01+11:00 https://pharmadispatch.com/news/atmo-biosciences-announces-publication-of-pivotal-clinical-study-results-supporting-initial-indi 2025-03-05T23:57:01+11:00 https://pharmadispatch.com/news/the-george-institute-welcomes-a-new-board-chair 2025-03-06T00:31:01+11:00 https://pharmadispatch.com/news/sepsis-survivors-at-high-risk-after-hospital-discharge-new-figures-reveal 2025-03-06T00:48:01+11:00 https://pharmadispatch.com/news/organons-bilal-somra-on-the-welcome-and-overdue-commitment-to-womens-health 2025-03-06T13:00:01+11:00 https://pharmadispatch.com/news/sanofi-consumer-health-business-secures-sustainability-certification 2025-03-06T02:34:01+11:00 https://pharmadispatch.com/news/version-20-of-medicines-australia-code-takes-pr-back-to-the-future 2025-03-07T13:00:01+11:00 https://pharmadispatch.com/news/six-pharma-companies-recognised-amongst-australias-best-workplaces-for-women 2025-03-07T13:46:01+11:00 https://pharmadispatch.com/news/organon-marks-international-womens-day-with-a-partnership-supporting-career-platform-for-women 2025-03-07T02:07:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-medicines-australia-gather-for-international-womens-day 2025-03-07T02:32:01+11:00 https://pharmadispatch.com/news/women-twice-as-likely-as-men-to-skip-a-prescription-because-of-cost 2025-03-07T14:00:01+11:00 https://pharmadispatch.com/news/kosi-challenge-fundraising-total-racing-towards-400000-as-pharma-cup-teams-add-to-totals 2025-03-07T14:00:01+11:00 https://pharmadispatch.com/news/omico-welcomes-new-government-investment-in-precision-medical-trial 2025-03-07T14:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-7-march 2025-03-08T02:33:01+11:00 https://pharmadispatch.com/news/public-summary-document-shows-slow-progress-on-weight-loss-therapy 2025-03-08T21:13:01+11:00 https://pharmadispatch.com/news/is-anybody-really-interested-in-bold-once-in-a-generation-reform 2025-03-10T14:00:01+11:00 https://pharmadispatch.com/news/discouraging-treatment-because-of-carbon-emissions-should-be-based-on-facts 2025-03-10T14:00:01+11:00 https://pharmadispatch.com/news/sanofis-people-and-pipeline-attract-new-head-of-medical-vaccines-mike-lee 2025-03-10T14:00:01+11:00 https://pharmadispatch.com/news/the-key-for-industry-is-good-ideas-that-will-make-the-system-better 2025-03-11T14:00:01+11:00 https://pharmadispatch.com/news/new-report-delivers-scathing-patient-assessment-of-pharmacs-culture 2025-03-11T14:00:01+11:00 https://pharmadispatch.com/news/kidney-health-australia-urges-those-at-risk-to-get-checked 2025-03-10T22:38:01+11:00 https://pharmadispatch.com/news/anatara-lifesciences-updates-on-garp-irritable-bowel-syndrome-trial 2025-03-10T22:49:01+11:00 https://pharmadispatch.com/news/total-continues-to-grow-as-astrazeneca-and-alexion-maintain-lead 2025-03-11T01:43:01+11:00 https://pharmadispatch.com/news/the-terrible-events-of-2023-were-born-of-a-decade-old-policy-failure 2025-03-12T00:07:01+11:00 https://pharmadispatch.com/news/what-i-love-about-this-event-is-that-it-brings-together-a-community-of-people-who-otherwise-feel 2025-03-12T01:22:01+11:00 https://pharmadispatch.com/news/new-technology-hits-australia-for-type-1-diabetes-patients 2025-03-12T14:00:01+11:00 https://pharmadispatch.com/news/australia-is-not-alone-in-using-rebate-payments-but-there-is-one-key-difference 2025-03-13T14:00:01+11:00 https://pharmadispatch.com/news/australian-company-confirms-the-location-of-clinical-trial 2025-03-13T14:00:01+11:00 https://pharmadispatch.com/news/medicines-funded-by-pharmac-tops-50-since-last-years-budget-boost 2025-03-13T14:00:01+11:00 https://pharmadispatch.com/news/wehi-researchers-solve-decades-long-mystery-on-parkinsons-disease-1 2025-03-14T16:00:01+11:00 https://pharmadispatch.com/news/astellas-cancer-therapy-approved-for-new-indication-in-earlier-prostate-cancer 2025-03-14T14:00:01+11:00 https://pharmadispatch.com/news/world-first-study-identifies-goldilocks-number-of-genes-to-include-in-pre-natal-screening 2025-03-13T22:35:01+11:00 https://pharmadispatch.com/news/kosi-climbers-about-to-embark-on-day-one-of-the-2025-challenge 2025-03-14T14:00:01+11:00 https://pharmadispatch.com/news/in-2025-the-us-is-more-likely-to-adopt-pbs-pricing-policies-than-oppose-them 2025-03-17T14:00:01+11:00 https://pharmadispatch.com/news/womens-health-listings-sparks-debate-over-the-timing-of-a-ministerial-nudge 2025-03-16T20:51:01+11:00 https://pharmadispatch.com/news/tthe-tga-registers-a-new-treatment-for-patients-with-the-most-commonly-diagnosed-type-of-early-b 2025-03-17T14:00:01+11:00 https://pharmadispatch.com/news/doctor-group-changes-position-on-weight-loss-therapies-and-the-pbs 2025-03-17T14:00:01+11:00 https://pharmadispatch.com/news/gedeon-richter-partners-with-patient-group-for-endometriosis-art-awards-ceremony 2025-03-16T23:21:01+11:00 https://pharmadispatch.com/news/astrazeneca-and-alexion-secure-back-to-back-pharma-cup-victory 2025-03-17T14:00:01+11:00 https://pharmadispatch.com/news/pharmac-confirms-acting-chief-as-board-launches-global-search-for-new-leader 2025-03-17T14:00:01+11:00 https://pharmadispatch.com/news/race-secures-ethics-approval-for-rc220-phase-1-solid-tumour-trial 2025-03-17T20:53:01+11:00 https://pharmadispatch.com/news/uk-industry-in-shock-over-significant-increase-in-payment-rate 2025-03-18T15:00:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-says-new-data-confirms-positive-tumour-uptake 2025-03-17T21:30:01+11:00 https://pharmadispatch.com/news/neurizon-therapeutics-updates-investors-on-initiatives-to-lift-clinical-hold 2025-03-17T21:38:01+11:00 https://pharmadispatch.com/news/nyrada-commences-recruitment-for-phase-one-clinical-trial 2025-03-17T21:48:01+11:00 https://pharmadispatch.com/news/regional-clinic-boosts-heart-meds-uptake-with-focused-initiative 2025-03-18T14:00:01+11:00 https://pharmadispatch.com/news/governor-general-supports-earlier-diagnosis-and-greater-awareness 2025-03-18T16:10:01+11:00 https://pharmadispatch.com/news/recognition-for-outstanding-results-in-medicines-australias-continuing-education-program 2025-03-19T14:00:01+11:00 https://pharmadispatch.com/news/caretaker-convention-creates-pbs-uncertainty-at-the-very-least 2025-03-19T14:00:01+11:00 https://pharmadispatch.com/news/all-manufacturers-decide-to-participate-in-the-second-cycle-of-us-price-negotiation 2025-03-19T15:48:01+11:00 https://pharmadispatch.com/news/us-price-negotiation-power-reveals-a-very-different-approach-to-patient-input 2025-03-20T14:00:01+11:00 https://pharmadispatch.com/news/island-raises-272-million-through-exercise-of-listed-options 2025-03-19T23:49:01+11:00 https://pharmadispatch.com/news/imugenes-azer-cel-granted-fda-fast-track-designation-in-blood-cancer 2025-03-20T00:01:01+11:00 https://pharmadispatch.com/news/brisbane-based-drugmaker-qbiotics-celebrates-25-years-since-its-creation 2025-03-20T00:15:01+11:00 https://pharmadispatch.com/news/if-our-own-government-wont-do-anything-why-not-welcome-intervention-from-another 2025-03-20T15:00:01+11:00 https://pharmadispatch.com/news/stakeholder-backing-for-another-pbs-co-pay-reduction 2025-03-20T15:59:01+11:00 https://pharmadispatch.com/news/sigma-releases-final-pre-merger-full-year-result-confirming-impact-of-cw-supply-contract 2025-03-20T20:32:01+11:00 https://pharmadispatch.com/news/the-minister-and-the-us-based-industry-have-a-lot-in-common-including-their-criticisms-of-the-pb 2025-03-20T21:25:01+11:00 https://pharmadispatch.com/news/new-nz-approval-clears-the-way-for-expanded-access-to-cystic-fibrosis-therapy 2025-03-20T23:57:01+11:00 https://pharmadispatch.com/news/the-week-in-review-dispatched-podcast-21-march 2025-03-21T04:48:01+11:00 https://pharmadispatch.com/news/medicines-australia-announces-appointment-of-new-board-chair 2025-03-21T05:38:01+11:00 https://pharmadispatch.com/news/when-the-facts-dont-support-you-accusatory-generalities-and-moral-outrage-are-the-only-option 2025-03-22T20:56:01+11:00 https://pharmadispatch.com/news/nanotechnology-could-improve-odds-in-treating-aggressive-breast-cancers 2025-03-24T14:00:01+11:00 https://pharmadispatch.com/news/half-a-million-australians-missing-out-on-cheaper-medicines-due-to-outdated-systems-1 2025-03-24T14:00:01+11:00 https://pharmadispatch.com/news/what-happens-to-the-conspiracy-when-the-industrys-criticisms-look-remarkably-similar-to-the-mini 2025-03-24T20:11:01+11:00 https://pharmadispatch.com/news/mark-butler-patients-are-waiting-too-long-and-as-the-health-minister-of-course-i-am-sorry-for-th 2025-03-24T22:44:01+11:00 https://pharmadispatch.com/news/australia-eye-therapy-company-now-focused-on-survival-after-clinical-trial-result 2025-03-25T14:00:01+11:00 https://pharmadispatch.com/news/another-day-and-another-example-to-add-to-the-motherload-of-bad-ideas 2025-03-25T20:57:01+11:00 https://pharmadispatch.com/news/former-speaker-of-the-house-appointed-as-official-patron-of-rare-cancers-australia 2025-03-26T00:27:01+11:00 https://pharmadispatch.com/news/surely-we-can-all-do-better-than-the-nonsense-of-the-past-few-weeks 2025-03-26T06:16:01+11:00 https://pharmadispatch.com/news/budget-reveals-wholesaling-arrangements-as-a-future-focus 2025-03-26T06:26:01+11:00 https://pharmadispatch.com/news/a-mature-response-that-deals-with-the-childish-political-dog-whistles 2025-03-27T06:00:01+11:00 https://pharmadispatch.com/news/when-it-comes-to-the-pbs-and-budgets-the-best-guide-to-the-future-is-the-past 2025-03-26T20:37:01+11:00 https://pharmadispatch.com/news/daiichi-sankyo-people-and-culture-head-recognised-as-healthcare-businesswomens-association-lumin 2025-03-26T21:19:01+11:00 https://pharmadispatch.com/news/medicines-australia-launches-edition-20-of-its-code-of-conduct 2025-03-27T14:00:01+11:00 https://pharmadispatch.com/news/debate-has-provided-the-most-effective-platform-to-focus-attention-on-pbs-problems 2025-03-27T22:04:01+11:00 https://pharmadispatch.com/news/work-of-the-hta-review-implementation-group-to-continue-during-caretaker-period 2025-03-28T14:00:01+11:00 https://pharmadispatch.com/news/amplia-therapeutics-reports-updated-data-from-pancreatic-cancer-trial 2025-03-28T02:07:01+11:00 https://pharmadispatch.com/news/neuren-initiates-development-of-nnz-2591-to-treat-hie-in-newborns 2025-03-28T02:08:01+11:00 https://pharmadispatch.com/news/mesoblast-says-its-fda-approved-mesenchymal-stromal-cell-therapy-available-for-sale-in-the-us 2025-03-28T02:09:01+11:00 https://pharmadispatch.com/news/health-department-launches-review-of-blood-products-supply 2025-03-28T03:04:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-28-march 2025-03-28T23:18:01+11:00 https://pharmadispatch.com/news/broader-pbs-listing-recognises-cardioprotective-benefits-of-sglt-2-inhibitor-therapy 2025-03-31T14:00:01+11:00 https://pharmadispatch.com/news/new-government-report-reveals-the-emerging-impact-of-major-reform 2025-03-31T14:00:01+11:00 https://pharmadispatch.com/news/election-writs-trigger-timeline-for-the-release-of-remaining-budgeted-decisions 2025-03-31T14:00:01+11:00 https://pharmadispatch.com/news/bionsw-launches-bioinvest-catalyst-events-to-support-life-sciences-investment-in-nsw 2025-03-31T20:22:01+11:00 https://pharmadispatch.com/news/first-targeted-treatment-on-the-pbs-for-rare-unpredictable-and-debilitating-autoimmune-disease 2025-04-01T14:00:01+11:00 https://pharmadispatch.com/news/last-weeks-budget-a-missed-opportunity-for-fairer-policies-to-support-not-for-profits 2025-04-02T14:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-forms-aboriginal-and-torres-strait-islander-health-advisory-council 2025-04-01T14:00:01+11:00 https://pharmadispatch.com/news/ipsen-welcomes-tga-registration-of-treatment-for-patients-with-primary-biliary-cholangiti 2025-04-01T14:00:01+11:00 https://pharmadispatch.com/news/opthea-announces-decision-to-discontinue-wet-amd-clinical-trials 2025-04-01T03:03:01+11:00 https://pharmadispatch.com/news/gsk-brings-melbourne-discovered-treatment-to-australian-patients 2025-04-01T14:00:01+11:00 https://pharmadispatch.com/news/the-grand-us-conspiracy-against-the-pbs-amounts-to-nothing 2025-04-01T21:46:01+11:00 https://pharmadispatch.com/news/diabetes-australia-calls-for-election-focus-on-wider-access-to-technologies 2025-04-02T03:22:01+11:00 https://pharmadispatch.com/news/immunisation-coalition-says-vaccinate-now-as-flu-cases-surge 2025-04-03T14:00:01+11:00 https://pharmadispatch.com/news/anticipated-therapies-and-not-so-anticipated-dominate-july-pbac-agenda 2025-04-03T02:52:01+11:00 https://pharmadispatch.com/news/wesfarmers-health-opens-new-pharmacy-fulfiment-centre-in-brisbane 2025-04-03T04:24:01+11:00 https://pharmadispatch.com/news/not-even-medicines-australia-believes-the-country-is-capable-of-a-mature-discussion-about-the-pb 2025-04-03T21:42:01+11:00 https://pharmadispatch.com/news/pharmx-launches-new-supplier-portal-to-accelerate-supplier-to-pharmacy-trade-integration 2025-04-04T03:25:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-companies-issue-cautious-responses-to-us-tariff-announcement 2025-04-04T14:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-4-april 2025-04-05T00:30:01+11:00 https://pharmadispatch.com/news/theres-nothing-wrong-with-incrementalism-we-just-need-to-be-honest-about-it 2025-04-07T13:00:01+10:00 https://pharmadispatch.com/news/new-zealand-plans-to-legislate-rule-of-two-to-accelerate-regulatory-approvals 2025-04-07T13:00:01+10:00 https://pharmadispatch.com/news/next-stop-is-a-review-of-existing-trade-agreements-including-australia 2025-04-07T00:27:01+10:00 https://pharmadispatch.com/news/late-post-budget-pbs-listings-confirmed-in-pre-election-budget-outlook 2025-04-08T13:00:01+10:00 https://pharmadispatch.com/news/can-i-just-say-that-i-have-been-horrified-through-this-whole-process-that-around-that-hasnt-been 2025-04-08T04:32:01+10:00 https://pharmadispatch.com/news/first-face-to-face-meeting-to-work-on-hta-review-implementation-work-plan 2025-04-08T13:00:01+10:00 https://pharmadispatch.com/news/most-of-what-will-confront-the-minister-after-the-election-will-be-business-as-usual 2025-04-09T13:00:01+10:00 https://pharmadispatch.com/news/leading-australian-health-companies-provide-updates-on-us-tariff-announcement 2025-04-09T13:00:01+10:00 https://pharmadispatch.com/news/uk-responds-to-global-insecurity-by-investing-in-new-health-data-service-and-accelerating-trials 2025-04-09T13:00:01+10:00 https://pharmadispatch.com/news/baker-says-advanced-omics-technology-will-supercharge-cardiovascular-research 2025-04-09T02:32:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-announces-the-completion-of-placement 2025-04-09T02:34:01+10:00 https://pharmadispatch.com/news/universal-hepatitis-b-testing-needed-to-stop-rise-in-liver-cancer-deaths 2025-04-09T02:37:01+10:00 https://pharmadispatch.com/news/atomo-announces-national-scale-up-of-publicly-funded-hiv-self-test-vending-machines 2025-04-09T02:40:01+10:00 https://pharmadispatch.com/news/wehi-says-study-puts-first-long-covid-treatment-on-horizon 2025-04-09T19:49:01+10:00 https://pharmadispatch.com/news/us-report-acknowledges-china-is-now-the-leader-in-global-biotechnology 2025-04-10T13:00:01+10:00 https://pharmadispatch.com/news/osteopore-secures-european-approval-for-custom-orthopaedic-and-cranial-implants 2025-04-09T23:21:01+10:00 https://pharmadispatch.com/news/president-announces-90-day-pause-on-higher-tariffs-but-pharma-fate-remains-unclear 2025-04-10T14:49:01+10:00 https://pharmadispatch.com/news/icon-cancer-centre-and-omico-partner-to-expand-access-to-precision-oncology-1 2025-04-10T15:18:01+10:00 https://pharmadispatch.com/news/pharmac-to-fund-wider-access-to-medicines-following-bundle-agreement-with-abbvie 2025-04-10T23:17:01+10:00 https://pharmadispatch.com/news/from-a-patient-point-of-view-the-point-is-that-we-can-provide-more-solutions-to-more-health-chal 2025-04-11T01:30:01+10:00 https://pharmadispatch.com/news/opthea-updates-investors-confirming-significant-staff-reduction 2025-04-11T03:54:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-week-in-review-11-april 2025-04-11T23:06:01+10:00 https://pharmadispatch.com/news/api-launches-new-b2b-e-commerce-platform-to-support-its-mroe-than-4000-customers 2025-04-14T11:00:01+10:00 https://pharmadispatch.com/news/sorry-minister-but-theres-no-world-in-which-you-kept-this-election-commitment-to-newborns 2025-04-14T11:00:01+10:00 https://pharmadispatch.com/news/pharmac-to-fund-novo-nordisks-long-acting-insulin-therapy 2025-04-14T11:00:01+10:00 https://pharmadispatch.com/news/the-review-implementation-process-is-the-next-step-in-a-negotiation 2025-04-14T11:00:01+10:00 https://pharmadispatch.com/news/viiv-healthcare-australia-announces-recipients-of-2024-positive-action-community-grants 2025-04-15T13:00:01+10:00 https://pharmadispatch.com/news/us-fda-announces-plan-to-phase-out-animal-testing-in-drug-development 2025-04-15T13:00:01+10:00 https://pharmadispatch.com/news/this-could-be-a-path-forward-a-move-to-delay-or-both-and-weve-seen-it-before 2025-04-14T23:35:01+10:00 https://pharmadispatch.com/news/medicines-australia-appoints-new-senior-policy-executive 2025-04-15T13:00:01+10:00 https://pharmadispatch.com/news/investors-comfortable-as-trump-administration-says-pharma-tariffs-coming 2025-04-16T13:00:01+10:00 https://pharmadispatch.com/news/challenging-headlines-are-the-natural-consequence-of-disrupting-a-very-stale-debate 2025-04-16T01:14:01+10:00 https://pharmadispatch.com/news/astellas-pharma-australia-appoints-new-head-of-medical-affairs 2025-04-16T13:00:01+10:00 https://pharmadispatch.com/news/ucb-welcomes-new-tga-registration-for-monoclonal-antibody 2025-04-16T13:00:01+10:00 https://pharmadispatch.com/news/cartherics-announces-board-changes-including-a-new-chair 2025-04-16T19:32:01+10:00 https://pharmadispatch.com/news/uq-tests-vaccine-response-in-cepi-backed-150-day-moonshot-challenge 2025-04-16T19:47:01+10:00 https://pharmadispatch.com/news/australian-research-finds-turning-off-protein-may-help-prevent-liver-cancer 2025-04-16T20:32:01+10:00 https://pharmadispatch.com/news/a-mixed-bag-for-the-industry-in-trump-executive-order-on-medicine-pricing 2025-04-17T13:00:01+10:00 https://pharmadispatch.com/news/prescients-ptx-100-receives-us-fda-fast-track-designation 2025-04-16T23:01:01+10:00 https://pharmadispatch.com/news/telix-says-ipax-linz-study-shows-promising-efficacy-for-glioma-therapy-candidate 2025-04-16T23:14:01+10:00 https://pharmadispatch.com/news/lilly-records-another-win-in-weight-loss-in-trial-of-oral-glp-1-agonist 2025-04-22T13:00:01+10:00 https://pharmadispatch.com/news/australia-increasingly-isolated-after-europe-approves-alzheimers-therapy 2025-04-22T13:00:01+10:00 https://pharmadispatch.com/news/fda-removes-industry-representatives-from-its-advisory-committees 2025-04-22T13:00:01+10:00 https://pharmadispatch.com/news/arguing-over-the-proverbial-lifejacket-whilst-patients-are-in-the-water-drowning-shame 2025-04-22T12:00:01+10:00 https://pharmadispatch.com/news/pharmac-proposes-three-monthly-quantities-for-popular-asthma-inhalers 2025-04-22T13:00:01+10:00 https://pharmadispatch.com/news/neurizon-announces-the-appointment-of-new-chief-financial-officer 2025-04-22T21:10:01+10:00 https://pharmadispatch.com/news/race-says-patient-enrolment-opened-at-second-site-for-rc220-solid-tumour-trial 2025-04-22T22:49:01+10:00 https://pharmadispatch.com/news/recce-phase-2-trial-receives-additional-approval-for-treating-diabetic-patients-with-topical-gel 2025-04-22T22:50:01+10:00 https://pharmadispatch.com/news/anatara-provides-update-following-completion-of-analysis-of-phase-2-garp-ibs-clinical-trial 2025-04-22T22:52:01+10:00 https://pharmadispatch.com/news/mesoblast-says-ryoncil-payer-coverage-extended-to-over-100-million-americans 2025-04-22T22:54:01+10:00 https://pharmadispatch.com/news/us-trade-agenda-looks-mostly-disinterested-in-pharmaceuticals 2025-04-23T13:00:01+10:00 https://pharmadispatch.com/news/reflecting-the-experience-of-people-living-with-cancer-pfizers-new-campaign-part-of-the-story-se 2025-04-23T13:00:01+10:00 https://pharmadispatch.com/news/roche-announces-historice-investment-to-build-us-manufacturing-base 2025-04-23T14:40:01+10:00 https://pharmadispatch.com/news/you-need-to-understand-that-health-technology-assessment-is-not-an-enabler 2025-04-24T13:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-weeks-in-review-24-april 2025-04-24T04:05:01+10:00 https://pharmadispatch.com/news/tga-approved-new-indication-for-gsks-rsv-vaccine 2025-04-24T14:43:01+10:00 https://pharmadispatch.com/news/government-funding-for-new-nasal-spray-ends-three-decade-drought 2025-04-28T00:00:01+10:00 https://pharmadispatch.com/news/repurposed-diabetes-drug-could-deliver-gains-for-people-living-with-major-joint-pain 2025-04-28T00:00:01+10:00 https://pharmadispatch.com/news/march-pbac-delivers-outcomes-for-high-profile-pre-funded-cancer-therapy 2025-04-28T00:00:01+10:00 https://pharmadispatch.com/news/dimerix-says-fda-confirms-proteinuria-as-acceptable-endpoint-for-dmx-200 2025-04-28T19:58:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-doses-first-patient-in-us-phase-2b-imaging-study-of-brain-metastasis 2025-04-28T21:16:01+10:00 https://pharmadispatch.com/news/recce-pharmaceuticals-enters-research-and-development-agreement-with-us-defence 2025-04-28T21:41:01+10:00 https://pharmadispatch.com/news/stakeholders-welcome-the-pbs-listing-of-abbvies-blood-cancer-therapy 2025-04-28T13:00:01+10:00 https://pharmadispatch.com/news/new-survey-confirms-significant-interest-in-accessing-weight-loss-therapies 2025-04-29T01:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-appoints-new-communications-director 2025-04-29T01:00:01+10:00 https://pharmadispatch.com/news/these-system-shifting-therapies-come-along-every-few-years-but-this-is-a-little-different 2025-04-30T01:00:01+10:00 https://pharmadispatch.com/news/game-changer-clinical-trial-launches-for-australias-second-deadliest-cancer 2025-04-30T01:00:01+10:00 https://pharmadispatch.com/news/pfizer-commissioned-survey-reveals-rising-gp-concerns-over-medical-misinformation 2025-04-29T13:00:01+10:00 https://pharmadispatch.com/news/cultural-review-delivers-a-scathing-assessment-of-new-zealands-pharmac 2025-04-29T13:00:01+10:00 https://pharmadispatch.com/news/government-funds-new-targeted-medicine-for-aggressive-lung-cancer 2025-04-30T19:27:01+10:00 https://pharmadispatch.com/news/pbs-listing-for-tevas-treatment-for-motor-neurone-disease 2025-05-01T00:36:01+10:00 https://pharmadispatch.com/news/icon-partners-with-nuffield-health-for-three-new-cancer-centres 2025-05-01T01:35:01+10:00 https://pharmadispatch.com/news/merck-healthcare-leader-joins-brain-cancer-australia-charity-board 2025-05-01T02:25:01+10:00 https://pharmadispatch.com/news/pbs-listing-for-lundbecks-long-acting-injectable-for-schizophrenia 2025-05-01T01:00:01+10:00 https://pharmadispatch.com/news/new-report-shows-us-government-more-interested-in-cheese-names-than-the-pbs 2025-05-01T19:34:01+10:00 https://pharmadispatch.com/news/dimerix-secures-exclusive-one-of-the-largest-licensing-deals-in-australian-biotechnology 2025-05-01T21:45:01+10:00 https://pharmadispatch.com/news/major-parties-share-commitment-to-the-hta-review-process-and-no-pre-election-funding 2025-05-02T04:56:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-2-may 2025-05-02T22:02:01+10:00 https://pharmadispatch.com/news/stakeholders-should-hope-for-continuity-in-the-health-portfolio 2025-05-05T01:00:01+10:00 https://pharmadispatch.com/news/ucb-welcomes-the-pbs-listing-of-dual-acting-anti-seizure-medication 2025-05-04T19:22:01+10:00 https://pharmadispatch.com/news/new-immune-therapy-treatment-option-for-women-diagnosed-with-advanced-endometrial-cancer 2025-05-05T03:21:01+10:00 https://pharmadispatch.com/news/pharma-pharmacy-and-biotech-congratulate-government-for-re-election 2025-05-04T13:00:01+10:00 https://pharmadispatch.com/news/fda-grants-fast-track-designation-for-alteritys-ath434-to-treat-multiple-aystem-atrophy 2025-05-05T21:01:01+10:00 https://pharmadispatch.com/news/mark-butler-straight-back-to-work-as-focus-turns-to-issues-and-policy-commitments 2025-05-06T01:00:01+10:00 https://pharmadispatch.com/news/arovella-options-advances-baylor-college-of-technology-to-enhance-inkt-cell-platform 2025-05-05T21:33:01+10:00 https://pharmadispatch.com/news/positive-trial-result-for-immuteps-efti-in-combination-with-msds-anti-pd-1-therapy 2025-05-05T21:54:01+10:00 https://pharmadispatch.com/news/neurotech-says-nti164-shows-positive-tolerability-in-key-preclinical-toxicology-studies 2025-05-05T22:39:01+10:00 https://pharmadispatch.com/news/greg-hunt-to-chair-new-telehealth-sector-working-group 2025-05-06T13:00:01+10:00 https://pharmadispatch.com/news/australias-premier-medtech-investment-event-unites-investors-and-innovators-to-boost-sector-grow 2025-05-06T01:21:01+10:00 https://pharmadispatch.com/news/sigma-delivers-growth-following-the-completion-of-chemist-warehouse-merger 2025-05-06T21:11:01+10:00 https://pharmadispatch.com/news/trump-administration-to-streamline-pharma-manufacturing-and-increase-global-inspections 2025-05-06T21:40:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-calls-for-standardisation-of-access-to-asthma-treatment 2025-05-06T23:50:01+10:00 https://pharmadispatch.com/news/clinuvel-recruits-200-patients-for-phase-3-vitiligo-trial-of-scenesse 2025-05-07T19:54:01+10:00 https://pharmadispatch.com/news/europe-warned-to-adopt-positive-changes-in-response-us-investment-rush 2025-05-07T21:01:01+10:00 https://pharmadispatch.com/news/oncosil-medical-reports-positive-analysis-of-pancreatic-cancer-trial 2025-05-07T21:07:01+10:00 https://pharmadispatch.com/news/percheron-therapeutics-launches-bonus-loyalty-option-offer 2025-05-07T21:20:01+10:00 https://pharmadispatch.com/news/who-cares-about-the-pbs-when-just-the-threat-of-tariffs-secured-a-quarter-of-a-trillion-in-inves 2025-05-08T00:24:01+10:00 https://pharmadispatch.com/news/new-study-reveals-the-far-reaching-impact-of-ovarian-cancer 2025-05-08T01:52:01+10:00 https://pharmadispatch.com/news/internal-promotions-for-new-generation-of-leaders-at-astellas 2025-05-08T02:14:01+10:00 https://pharmadispatch.com/news/new-zealand-to-change-laws-to-promote-medical-conferences 2025-05-09T01:18:01+10:00 https://pharmadispatch.com/news/new-partnership-promotes-buy-local-for-homegrown-innovation 2025-05-09T01:28:01+10:00 https://pharmadispatch.com/news/australia-is-about-to-get-a-new-industry-minister 2025-05-09T01:06:01+10:00 https://pharmadispatch.com/news/sanofis-consumer-health-business-opella-becomes-a-standalone-company 2025-05-10T03:49:01+10:00 https://pharmadispatch.com/news/pharmac-funds-and-widens-access-to-melanoma-medicines 2025-05-12T00:00:01+10:00 https://pharmadispatch.com/news/vertex-welcomes-expanded-tga-approval-for-cystic-fibrosis-therapy 2025-05-10T03:52:01+10:00 https://pharmadispatch.com/news/who-are-legislated-conditional-listings-designed-to-limit-the-industry-or-the-minister 2025-05-11T19:27:01+10:00 https://pharmadispatch.com/news/non-descript-vagueness-on-pharmaceuticals-in-us-uk-bilateral-trade-agreement 2025-05-11T21:43:01+10:00 https://pharmadispatch.com/news/mark-butler-reappointed-to-lead-health-portfolio-1 2025-05-11T21:00:01+10:00 https://pharmadispatch.com/news/australia-has-been-managing-the-risk-of-international-reference-pricing-for-most-of-this-century 2025-05-12T08:00:01+10:00 https://pharmadispatch.com/news/australian-nursing-leader-makes-the-finalist-list-of-global-award 2025-05-12T08:00:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-accelerates-177lu-rad204-phase-1-dose-escalation-trial 2025-05-12T21:03:01+10:00 https://pharmadispatch.com/news/monash-scientists-secure-mrff-funding-to-find-new-medicines-for-dementia-by-lighting-up-human-br 2025-05-12T21:09:01+10:00 https://pharmadispatch.com/news/experienced-industry-executive-appointed-chair-of-tryptamine-therapeutics 2025-05-12T23:34:01+10:00 https://pharmadispatch.com/news/an-already-busy-fixed-ministerial-bandwidth-just-got-much-busier 2025-05-12T11:24:01+10:00 https://pharmadispatch.com/news/lilly-touts-weight-management-results-in-new-head-to-head-study 2025-05-13T02:07:01+10:00 https://pharmadispatch.com/news/health-stakeholders-welcome-the-reappointment-of-mark-butler 2025-05-13T03:28:01+10:00 https://pharmadispatch.com/news/pharma-stocks-rise-in-response-to-trumps-mfn-executive-order 2025-05-13T02:29:01+10:00 https://pharmadispatch.com/news/trumps-language-on-pricing-matches-australias-reflect-response-to-pbs-criticism 2025-05-13T15:16:01+10:00 https://pharmadispatch.com/news/new-administrative-order-confirms-the-total-move-of-ndis-to-health 2025-05-14T01:24:01+10:00 https://pharmadispatch.com/news/new-liberal-leader-sussan-ley-was-responsible-for-major-pbs-reforms 2025-05-14T02:56:01+10:00 https://pharmadispatch.com/news/lumos-advances-febridx-sales-with-imedical-purchase-order 2025-05-14T21:23:01+10:00 https://pharmadispatch.com/news/mark-butler-tasked-with-delivering-pbs-level-reduction-in-ndis-spending 2025-05-14T13:00:01+10:00 https://pharmadispatch.com/news/csl-behring-wins-major-international-pharmaceutical-engineering-award 2025-05-15T01:10:01+10:00 https://pharmadispatch.com/news/us-bio-joins-phrma-in-challenging-trump-over-most-favored-nation-order 2025-05-14T13:00:01+10:00 https://pharmadispatch.com/news/uk-health-secretary-identifies-weight-loss-therapies-as-one-solution-to-broader-issue 2025-05-15T21:28:01+10:00 https://pharmadispatch.com/news/portfolio-change-has-real-implications-for-stakeholders-with-a-revised-approach-required 2025-05-15T23:58:01+10:00 https://pharmadispatch.com/news/applications-now-open-for-moderna-mrna-focused-research-program 2025-05-16T03:04:01+10:00 https://pharmadispatch.com/news/novo-nordisk-oceania-announces-departure-of-cem-ozenc-to-lead-new-global-team 2025-05-15T23:53:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-16-may 2025-05-15T23:05:01+10:00 https://pharmadispatch.com/news/team-lilly-australia-taking-the-time-to-prioritise-wellbeing 2025-05-18T13:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-the-magnitude-of-the-challenge-facing-mark-butler 2025-05-18T13:00:01+10:00 https://pharmadispatch.com/news/we-need-to-be-honest-about-the-fact-our-governments-ruthlessly-dictate-the-terms-of-care 2025-05-17T23:14:01+10:00 https://pharmadispatch.com/news/fda-clears-the-first-blood-test-used-for-diagnosing-alzheimers-disease 2025-05-20T01:00:01+10:00 https://pharmadispatch.com/news/experts-urge-vigilance-with-rsv-ahead-of-winter-saying-its-as-serious-in-older-adults-as-it-is-i 2025-05-20T02:26:01+10:00 https://pharmadispatch.com/news/report-highlights-international-confidence-in-australian-clinical-trials 2025-05-20T02:36:01+10:00 https://pharmadispatch.com/news/medicines-australias-sharpened-post-election-language-on-reform 2025-05-21T02:26:01+10:00 https://pharmadispatch.com/news/industry-alarm-over-the-sudden-pursuit-of-surprise-uncertified-claims 2025-05-21T02:38:01+10:00 https://pharmadispatch.com/news/ndis-minister-restates-the-importance-of-nothing-about-us-without-us 2025-05-21T04:19:01+10:00 https://pharmadispatch.com/news/trump-administration-invites-companies-to-align-us-pricing-under-mfn-plan 2025-05-21T20:20:01+10:00 https://pharmadispatch.com/news/examples-are-important-as-evidence-of-the-problem-but-be-prepared-to-defend-them 2025-05-21T20:53:01+10:00 https://pharmadispatch.com/news/tga-approves-first-of-a-kind-medicine-for-early-symptomatic-alzheimers-disease 2025-05-21T22:32:01+10:00 https://pharmadispatch.com/news/i-think-we-have-to-step-up-and-help-him-to-understand-that-hes-got-to-deliver-on-it 2025-05-22T22:20:01+10:00 https://pharmadispatch.com/news/new-zealand-announces-12-month-prescription-duration-in-2025-budget 2025-05-22T23:57:01+10:00 https://pharmadispatch.com/news/merck-joins-forces-with-omico-to-improve-access-to-cancer-trials-in-australia 2025-05-23T00:16:01+10:00 https://pharmadispatch.com/news/health-department-shifts-its-position-on-uncertified-claims-to-semantics 2025-05-25T13:00:01+10:00 https://pharmadispatch.com/news/ustr-invites-stakeholder-input-on-the-impact-of-price-suppressing-policies 2025-05-25T21:39:01+10:00 https://pharmadispatch.com/news/life-science-leaders-on-australias-strengths-and-the-opportunity-to-do-more 2025-05-25T22:43:01+10:00 https://pharmadispatch.com/news/is-now-the-time-to-be-discussing-these-things-and-resisting-speical-pricing-arrangements 2025-05-26T20:03:01+10:00 https://pharmadispatch.com/news/pharmac-proposes-change-to-ensure-care-continuity-for-more-cancer-patients 2025-05-26T21:27:01+10:00 https://pharmadispatch.com/news/immuteps-efti-combination-meets-primary-endpoint-in-phase-2-soft-tissue-sarcoma 2025-05-26T22:14:01+10:00 https://pharmadispatch.com/news/nsw-government-to-improve-access-to-adhd-diagnosis-and-treatment 2025-05-27T00:39:01+10:00 https://pharmadispatch.com/news/leadership-transition-for-medical-affairs-professional-association 2025-05-27T01:12:01+10:00 https://pharmadispatch.com/news/how-can-you-not-be-sceptical-about-a-rigged-one-sided-process 2025-05-27T21:47:01+10:00 https://pharmadispatch.com/news/australian-led-enzamet-prostate-cancer-trials-to-present-data-at-asco-2025 2025-05-27T14:07:01+10:00 https://pharmadispatch.com/news/roche-advances-the-development-of-innovative-antibiotic 2025-05-27T14:29:01+10:00 https://pharmadispatch.com/news/cartherics-to-present-at-the-2025-bio-international-convention 2025-05-28T20:56:01+10:00 https://pharmadispatch.com/news/sussan-ley-confirms-the-reappointment-of-anne-ruston-to-health 2025-05-28T11:52:01+10:00 https://pharmadispatch.com/news/an-across-the-board-pbs-levy-would-be-a-tax-on-the-listing-and-pricing-process 2025-05-28T23:12:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-says-healthscope-collapse-provides-stark-warning 2025-05-29T01:42:01+10:00 https://pharmadispatch.com/news/anne-ruston-welcomes-her-reappointment-to-health-and-the-addition-of-ndis 2025-05-29T01:58:01+10:00 https://pharmadispatch.com/news/pricelien-pharmacy-launches-annual-event-with-national-menopause-project 2025-05-29T03:05:01+10:00 https://pharmadispatch.com/news/for-patients-its-about-understanding-their-experience-and-accessing-the-touch-points 2025-05-29T20:49:01+10:00 https://pharmadispatch.com/news/abbvie-australia-appoints-dr-carly-levetan-associate-medical-director 2025-05-30T02:29:01+10:00 https://pharmadispatch.com/news/tga-approves-new-therapy-for-children-with-growth-hormone-deficiency 2025-05-30T05:00:01+10:00 https://pharmadispatch.com/news/arrotex-pharmaceuticals-appointed-exclusive-partner-for-juniper-biologics 2025-05-30T05:08:01+10:00 https://pharmadispatch.com/news/dimerix-says-first-action3-trial-site-activated-in-japan-and-first-milestone-payment-triggered 2025-05-30T20:22:01+10:00 https://pharmadispatch.com/news/daiichi-sankyo-secures-certification-as-great-place-to-work 2025-06-01T20:09:01+10:00 https://pharmadispatch.com/news/ipsens-julien-dagher-promoted-to-european-leadership-role 2025-06-01T20:31:01+10:00 https://pharmadispatch.com/news/an-opportunity-for-reflection-on-the-need-to-humanise-pbs-decision-making 2025-06-01T21:06:01+10:00 https://pharmadispatch.com/news/pharmac-minister-sworn-in-as-new-zealands-deputy-prime-minister 2025-06-01T22:52:01+10:00 https://pharmadispatch.com/news/cardiex-receives-tga-approval-for-conneqt-pulse-arterial-health-monitor 2025-06-02T20:16:01+10:00 https://pharmadispatch.com/news/neurotech-announces-positive-human-pk-study-results-for-nti164 2025-06-02T20:23:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-reports-preclinical-lu177-b7h3-mab-data 2025-06-02T20:43:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-shadow-ministry-and-encourages-bipartisan-support-for-life-sciences-sector 2025-06-02T23:12:01+10:00 https://pharmadispatch.com/news/australian-innovation-could-revolutionise-the-early-detection-of-ovarian-cancer 2025-06-03T00:24:01+10:00 https://pharmadispatch.com/news/new-data-uncovers-our-most-painful-moments-as-access-to-treatment-expands 2025-06-03T03:10:01+10:00 https://pharmadispatch.com/news/the-needed-realignment-of-belief-certainty-and-scepticism-in-our-decision-making 2025-06-03T20:55:01+10:00 https://pharmadispatch.com/news/health-department-admits-review-of-blood-arrangements-is-considering-defunding-products 2025-06-03T12:31:01+10:00 https://pharmadispatch.com/news/tga-approves-lilly-glp-1-for-obstructive-sleep-apnoea 2025-06-04T01:24:01+10:00 https://pharmadispatch.com/news/sandoz-calls-for-reforms-to-unlock-biosimilar-savings 2025-06-04T01:57:01+10:00 https://pharmadispatch.com/news/bms-australia-celebrates-silver-tier-employer-status-at-australian-lgbtq-inclusion-awards 2025-06-04T02:45:01+10:00 https://pharmadispatch.com/news/arrotex-launches-newly-developed-treatment-for-australians-with-common-skin-conditions-on-the-pb 2025-06-04T03:08:01+10:00 https://pharmadispatch.com/news/jordan-steele-john-reappointed-to-represent-greens-in-health-portfolio 2025-06-04T20:11:01+10:00 https://pharmadispatch.com/news/ausbiotech-and-austrade-launch-partnership-to-accelerate-global-expansion-of-life-sciences-indus 2025-06-05T03:15:01+10:00 https://pharmadispatch.com/news/cannabis-council-australia-appoints-ceo-to-lead-next-phase-of-industry-reform 2025-06-05T03:24:01+10:00 https://pharmadispatch.com/news/wesfarmers-health-acquires-pharmacy-4-less-group 2025-06-05T03:35:01+10:00 https://pharmadispatch.com/news/clinical-trial-success-kicks-off-5m-fund-raising-round-for-was-lixa 2025-06-05T19:51:01+10:00 https://pharmadispatch.com/news/clarity-announces-positive-top-line-results-from-disco-trial 2025-06-05T20:49:01+10:00 https://pharmadispatch.com/news/uk-moves-to-pricing-changes-as-australian-based-companies-baulk-at-listings 2025-06-05T22:08:01+10:00 https://pharmadispatch.com/news/my-experience-was-awful-i-really-had-to-fight-to-be-taken-seriously-and-advocate-for-myself 2025-06-06T00:37:01+10:00 https://pharmadispatch.com/news/health-department-amends-published-blood-review-information 2025-06-06T01:07:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-6-june 2025-06-06T10:12:01+10:00 https://pharmadispatch.com/news/australian-dementia-network-monash-university-and-lilly-sign-research-collaboration 2025-06-06T22:48:01+10:00 https://pharmadispatch.com/news/early-intervention-on-chronic-kidney-disease-would-deliver-economic-boost 2025-06-09T01:17:01+10:00 https://pharmadispatch.com/news/you-certainly-couldnt-accuse-this-system-of-haste-and-this-might-need-ministerial-intervention 2025-06-09T20:22:01+10:00 https://pharmadispatch.com/news/companies-confirm-renewed-push-for-streamlined-immunotherapy-listing-process 2025-06-09T20:26:01+10:00 https://pharmadispatch.com/news/new-study-reveals-superior-efficacy-of-cell-based-flu-vaccine 2025-06-10T20:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-says-delayed-listings-would-not-be-a-surprising-response 2025-06-10T12:00:01+10:00 https://pharmadispatch.com/news/advocacy-group-pleading-with-the-nsw-government-to-establish-men-b-vaccine-program 2025-06-10T22:21:01+10:00 https://pharmadispatch.com/news/what-will-the-hta-review-implementation-advisory-group-iag-do-if-the-pbac-rejects-the-process 2025-06-11T21:49:01+10:00 https://pharmadispatch.com/news/pfizer-chief-sets-out-the-potential-implications-of-most-favored-naton-pricing 2025-06-11T22:46:01+10:00 https://pharmadispatch.com/news/mark-butler-starts-the-process-of-ndis-pricing-reform 2025-06-12T01:18:01+10:00 https://pharmadispatch.com/news/novo-nordisk-partners-with-heart-of-australia-to-expand-clinical-trial-access 2025-06-12T20:03:01+10:00 https://pharmadispatch.com/news/specialised-therapeutics-expands-partnership-with-incyte-to-include-two-additional-therapies 2025-06-12T21:16:01+10:00 https://pharmadispatch.com/news/msd-australia-and-new-zealand-certified-a-great-place-to-work 2025-06-13T01:39:01+10:00 https://pharmadispatch.com/news/medicines-australia-establishes-radiopharmaceuticals-working-group 2025-06-13T02:02:01+10:00 https://pharmadispatch.com/news/new-immunisation-strategy-highlights-covid-impact-priority-patients-and-new-technologies 2025-06-13T03:20:01+10:00 https://pharmadispatch.com/news/specialised-therapeutics-expands-partnership-with-incyte-to-include-two-additional-therapies-1 2025-06-13T14:48:01+10:00 https://pharmadispatch.com/news/go-healthy-with-taiwan-invites-submissions-from-australian-health-innovators 2025-06-13T21:01:01+10:00 https://pharmadispatch.com/news/why-not-construct-an-off-ramp-based-on-what-you-were-going-to-do-anyway 2025-06-15T20:45:01+10:00 https://pharmadispatch.com/news/there-is-a-very-real-impact-on-australian-patients-and-clinicians 2025-06-15T23:23:01+10:00 https://pharmadispatch.com/news/this-could-be-the-canary-in-the-coal-mine-but-a-lot-of-canaries-have-already-died 2025-06-15T23:47:01+10:00 https://pharmadispatch.com/news/amplia-says-pathological-complete-response-in-patient-from-accent-trial 2025-06-16T20:41:01+10:00 https://pharmadispatch.com/news/confirmation-the-uk-has-agreed-to-review-medicine-prices-in-response-to-us-demand 2025-06-16T21:20:01+10:00 https://pharmadispatch.com/news/these-systems-are-and-always-have-been-more-similar-than-most-realise 2025-06-16T21:40:01+10:00 https://pharmadispatch.com/news/australian-company-secures-us-food-drug-administration-fda-approves-investigational-new-drug-ind 2025-06-17T02:49:01+10:00 https://pharmadispatch.com/news/australias-system-is-more-uniform-than-the-us-but-not-uniformly-better 2025-06-17T22:51:01+10:00 https://pharmadispatch.com/news/us-fda-approves-csls-treatment-for-hereditary-angioedema 2025-06-18T03:30:01+10:00 https://pharmadispatch.com/news/canadian-appointed-to-lead-new-zealands-pharmac 2025-06-18T03:36:01+10:00 https://pharmadispatch.com/news/montu-pushes-for-national-standards-at-productivity-commission-inquiry 2025-06-18T04:01:01+10:00 https://pharmadispatch.com/news/new-survey-reveals-role-of-credit-cards-and-borrowing-in-healthcare-access 2025-06-18T20:21:01+10:00 https://pharmadispatch.com/news/one-csl-innovation-that-allows-for-a-direct-and-timely-comparison 2025-06-18T21:17:01+10:00 https://pharmadispatch.com/news/pilot-study-confirms-adjunct-nb-uvb-needed-to-activate-repigmentation-in-vitiligo 2025-06-18T21:57:01+10:00 https://pharmadispatch.com/news/imugene-announces-us-patent-allowance-for-oncarlytics 2025-06-18T22:04:01+10:00 https://pharmadispatch.com/news/government-expands-access-to-melatonin-and-psilocybin 2025-06-19T01:50:01+10:00 https://pharmadispatch.com/news/amplia-announces-second-confirmed-complete-response-in-accent-trial 2025-06-19T20:52:01+10:00 https://pharmadispatch.com/news/even-if-most-favored-nation-impacts-pricing-in-the-us-its-impact-on-total-health-spending-will-b 2025-06-19T21:56:01+10:00 https://pharmadispatch.com/news/advocate-and-founder-of-rare-cancers-australia-steps-down-as-chair 2025-06-20T12:47:01+10:00 https://pharmadispatch.com/news/gilead-confirms-australian-submission-for-major-hiv-innovation-following-us-approval 2025-06-20T12:54:01+10:00 https://pharmadispatch.com/news/wa-budget-includes-significant-investments-in-health-and-medical-research 2025-06-20T12:56:01+10:00 https://pharmadispatch.com/news/an-ideological-darkness-underpins-our-systems-decision-making 2025-06-20T21:10:01+10:00 https://pharmadispatch.com/news/glp-1-pill-study-marks-potential-new-chapter-in-treating-diabetes-and-weight-loss 2025-06-20T22:11:01+10:00 https://pharmadispatch.com/news/awards-recognise-and-celebrate-the-lived-experience-in-health-research 2025-06-21T00:32:01+10:00 https://pharmadispatch.com/news/tga-licensed-compounders-call-for-review-to-ensure-sustainability 2025-06-21T01:32:01+10:00 https://pharmadispatch.com/news/outcomes-published-from-meeting-the-pbac-was-directed-to-hold 2025-06-22T21:22:01+10:00 https://pharmadispatch.com/news/amgen-backs-women-in-cancer-research-as-survey-reveals-workforce-risks 2025-06-24T13:00:01+10:00 https://pharmadispatch.com/news/millions-of-australians-unaware-of-the-simple-test-that-can-expose-australias-most-notorious-sil 2025-06-24T13:00:01+10:00 https://pharmadispatch.com/news/tryptamine-therapeutics-secures-human-ethics-approval-for-binge-eating-disorder-trial 2025-06-23T21:55:01+10:00 https://pharmadispatch.com/news/immutep-announces-positive-update-from-phase-1-study-of-imp761 2025-06-23T22:09:01+10:00 https://pharmadispatch.com/news/rare-cancers-awareness-day-to-focus-on-the-lived-experience-of-patients 2025-06-24T13:00:01+10:00 https://pharmadispatch.com/news/proteomics-announces-release-of-new-promarkerd-test-for-predicting-diabetic-kidney-disease 2025-06-23T22:50:01+10:00 https://pharmadispatch.com/news/naccho-announces-2025-aboriginal-and-torres-strait-islander-pharmacist-scholarship-recipients 2025-06-23T23:21:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast 2025-06-24T01:37:01+10:00 https://pharmadispatch.com/news/vertex-announces-new-expanded-australian-reimbursement-for-cf-therapy 2025-06-24T13:00:01+10:00 https://pharmadispatch.com/news/us-phrma-puts-australia-in-the-group-of-innovation-free-riders 2025-06-25T13:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-leads-global-engagement-to-strengthen-australias-life-sciences-sector 2025-06-25T13:00:01+10:00 https://pharmadispatch.com/news/fivephusion-announces-successful-completion-of-phase-1-component-of-paediatric-brain-cancer-tria 2025-06-25T01:29:01+10:00 https://pharmadispatch.com/news/nt-doctors-want-action-as-whooping-cough-cases-soar 2025-06-25T13:00:01+10:00 https://pharmadispatch.com/news/mark-butler-clarifies-meaning-of-quick-pbs-listings-statement 2025-06-25T13:00:01+10:00 https://pharmadispatch.com/news/noxopharm-says-clinical-trial-recruitment-progressing-rapidly 2025-06-25T20:43:01+10:00 https://pharmadispatch.com/news/qbiotics-candidate-produces-strong-efficacy-result-in-soft-tissue-sarcoma-trial 2025-06-25T21:10:01+10:00 https://pharmadispatch.com/news/leukaemia-foundation-calls-for-urgent-action-to-address-diagnosis-and-treatment-gaps 2025-06-25T22:25:01+10:00 https://pharmadispatch.com/news/cleo-strengthens-fda-submission-following-access-to-globally-recognised-biobank 2025-06-26T00:24:01+10:00 https://pharmadispatch.com/news/1-july-research-lagging-for-sarcoma-despite-accounting-for-one-third-of-adolescent-cancer-deaths 2025-07-01T12:00:01+10:00 https://pharmadispatch.com/news/new-zealand-to-streamline-access-to-adhd-treatments 2025-06-26T13:00:01+10:00 https://pharmadispatch.com/news/medadvisor-progressing-strategic-review-including-potential-sale-of-australian-operation 2025-06-27T13:00:01+10:00 https://pharmadispatch.com/news/hospital-pharmacists-call-for-cancer-care-reform-on-rare-cancers-awareness-day 2025-06-27T13:00:01+10:00 https://pharmadispatch.com/news/mark-butler-retains-position-on-critical-cabinet-committee 2025-06-27T01:43:01+10:00 https://pharmadispatch.com/news/atmo-biosciences-receives-us-fda-clearance-for-ingestible-gas-sensing-capsule 2025-06-27T21:08:01+10:00 https://pharmadispatch.com/news/pyc-therapeutics-to-present-progress-in-phelan-mcdermid-syndrome-at-global-congress 2025-06-27T21:18:01+10:00 https://pharmadispatch.com/news/percheron-licenses-phase-2-ready-immuno-oncology-candidate-from-hummingbird 2025-06-27T21:29:01+10:00 https://pharmadispatch.com/news/takeda-therapy-now-available-through-the-pbs-for-serious-viral-infection 2025-07-01T12:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-27-june 2025-06-28T01:48:01+10:00 https://pharmadispatch.com/news/incoming-brief-recommends-doing-more-and-reviewing-less 2025-06-28T22:44:01+10:00 https://pharmadispatch.com/news/incoming-brief-advises-minister-to-dampen-expectations-on-hta-review 2025-06-30T09:00:01+10:00 https://pharmadispatch.com/news/the-focus-on-system-and-patient-productivity-is-an-open-door-opportunity 2025-06-30T09:00:01+10:00 https://pharmadispatch.com/news/arovella-therapeutics-announces-the-retirement-of-non-executive-chair 2025-06-30T20:26:01+10:00 https://pharmadispatch.com/news/ltr-pharma-achieves-key-fda-milestone-through-extractables-study 2025-06-30T20:48:01+10:00 https://pharmadispatch.com/news/the-real-question-is-why-expectations-were-so-high-in-the-first-place 2025-07-01T12:00:01+10:00 https://pharmadispatch.com/news/national-pharmacies-appoints-experienced-industry-leader-as-new-ceo 2025-07-01T12:00:01+10:00 https://pharmadispatch.com/news/tetratherix-lists-on-the-asx-following-successful-ipo 2025-07-01T00:14:01+10:00 https://pharmadispatch.com/news/moderna-announces-positive-phase-3-result-of-influenza-vaccines 2025-07-01T13:54:01+10:00 https://pharmadispatch.com/news/new-treatment-option-for-australians-with-early-breast-cancer-at-high-risk-of-recurrence 2025-07-02T13:00:01+10:00 https://pharmadispatch.com/news/expanded-listing-for-bristol-myers-squibbs-pd-1-to-include-bladder-cancer 2025-07-02T13:00:01+10:00 https://pharmadispatch.com/news/wesfarmers-health-launches-pilot-pharmacy-format-instantscripts-pharmacy-health-hub 2025-07-02T13:00:01+10:00 https://pharmadispatch.com/news/the-industry-backs-productivity-focus-for-albanese-governments-second-term 2025-07-02T13:00:01+10:00 https://pharmadispatch.com/news/new-zealands-medsafe-and-pharmacy-directed-to-explore-ai-use-to-expedite-assessments 2025-07-02T13:00:01+10:00 https://pharmadispatch.com/news/island-pharmaceuticals-announces-the-appointment-of-new-chair 2025-07-02T20:42:01+10:00 https://pharmadispatch.com/news/amplia-therapeutics-announces-additional-confirmed-partial-response-recorded-in-accent-trial 2025-07-02T20:48:01+10:00 https://pharmadispatch.com/news/prescient-therapeutics-opens-share-purchase-plan 2025-07-02T20:53:01+10:00 https://pharmadispatch.com/news/neurizon-announces-global-agreement-with-elanco-for-the-commercialisation-of-nuz-001 2025-07-02T21:10:01+10:00 https://pharmadispatch.com/news/medadvisor-announces-agreement-confirming-the-sale-of-australian-business 2025-07-03T13:00:01+10:00 https://pharmadispatch.com/news/draft-national-health-genomics-policy-framework-out-for-consultation 2025-07-03T13:00:01+10:00 https://pharmadispatch.com/news/gbma-announces-planned-departure-of-long-standing-ceo 2025-07-03T01:58:01+10:00 https://pharmadispatch.com/news/framework-pushes-genomics-funding-to-a-review-that-is-mostly-silent-on-it 2025-07-03T20:56:01+10:00 https://pharmadispatch.com/news/whats-the-point-of-pretending-that-australia-doesnt-free-ride-on-us-innovation 2025-07-03T23:19:01+10:00 https://pharmadispatch.com/news/ausbiotech-seeking-a-head-of-investment-to-drive-sector-growth 2025-07-04T01:34:01+10:00 https://pharmadispatch.com/news/medicines-australia-backs-focus-on-listings-and-productivity-in-government-brief 2025-07-04T03:18:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast 2025-07-05T00:04:01+10:00 https://pharmadispatch.com/news/it-signals-the-need-to-renegotiate-the-expiring-statutory-pricing-framework 2025-07-06T20:41:01+10:00 https://pharmadispatch.com/news/uks-ten-year-plan-backs-faster-access-but-industry-laments-lack-of-investment 2025-07-07T13:00:01+10:00 https://pharmadispatch.com/news/pharmac-minister-prepares-to-deliver-letter-of-expectations 2025-07-07T13:00:01+10:00 https://pharmadispatch.com/news/pyc-therapeutics-to-progress-polycystic-kidney-disease-trial 2025-07-07T19:35:01+10:00 https://pharmadispatch.com/news/neurotechs-rett-syndrome-trial-results-published-in-scientific-journal 2025-07-07T20:10:01+10:00 https://pharmadispatch.com/news/medadvisor-restates-focus-on-us-following-completion-of-anz-business-sale 2025-07-08T13:00:01+10:00 https://pharmadispatch.com/news/south-australia-expanded-flu-vax-availability-in-response-to-record-outbreak 2025-07-08T13:00:01+10:00 https://pharmadispatch.com/news/more-companies-are-exercising-their-rights-and-they-are-perfectly-entitled 2025-07-08T00:41:01+10:00 https://pharmadispatch.com/news/consortium-established-to-co-design-new-telehealth-standards 2025-07-08T21:26:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-27-new-members-in-first-half-of-2025 2025-07-09T13:00:01+10:00 https://pharmadispatch.com/news/health-spending-under-increasing-pressure-as-department-looks-to-offsets 2025-07-09T13:00:01+10:00 https://pharmadispatch.com/news/island-expands-portfolio-with-the-acquisition-of-antiviral 2025-07-09T20:38:01+10:00 https://pharmadispatch.com/news/this-debate-over-us-tariffs-might-be-the-dumbest-in-pbs-history 2025-07-10T02:03:01+10:00 https://pharmadispatch.com/news/might-australia-be-just-a-little-hypocritical-on-pharmaceutical-tariffs 2025-07-10T02:56:01+10:00 https://pharmadispatch.com/news/stakeholders-welcome-medicinal-cannabis-crackdown 2025-07-10T03:41:01+10:00 https://pharmadispatch.com/news/is-this-the-missing-link-in-pharma-engagement-strategies 2025-07-10T03:53:01+10:00 https://pharmadispatch.com/news/medibank-to-subsidise-pharmacogenetic-testing-for-members 2025-07-10T22:38:01+10:00 https://pharmadispatch.com/news/the-debate-is-frustrating-but-it-is-an-opportunity-to-amplify-acknowledged-concerns 2025-07-10T22:40:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-10-july 2025-07-11T04:22:01+10:00 https://pharmadispatch.com/news/new-zealand-moves-again-to-make-it-easier-to-access-medicines 2025-07-11T13:00:01+10:00 https://pharmadispatch.com/news/australia-is-in-no-position-to-lecture-the-us-about-affordable-access-to-medicines 2025-07-14T13:00:01+10:00 https://pharmadispatch.com/news/biotintelect-amongst-groups-funded-to-foster-research-commercialisation 2025-07-14T00:49:01+10:00 https://pharmadispatch.com/news/hta-reform-is-fine-but-why-is-the-underpinning-framework-immutable 2025-07-15T13:00:01+10:00 https://pharmadispatch.com/news/patient-voice-initiative-announced-the-appointment-of-new-president 2025-07-15T13:00:01+10:00 https://pharmadispatch.com/news/imugene-reports-two-additional-complete-responses-in-azer-cel-car-t-phase-1b-trial 2025-07-14T22:38:01+10:00 https://pharmadispatch.com/news/amplia-therapeutics-announces-additional-confirmed-partial-response-in-accent-trial 2025-07-14T22:53:01+10:00 https://pharmadispatch.com/news/olympians-join-medical-experts-urging-parents-and-young-adults-on-meningococcal-vaccine 2025-07-15T13:00:01+10:00 https://pharmadispatch.com/news/the-need-to-correct-a-profound-misconception-of-ethical-decision-making 2025-07-15T19:48:01+10:00 https://pharmadispatch.com/news/new-collaboration-between-viral-vector-manufacturing-facilityand-cell-therapies 2025-07-16T01:43:01+10:00 https://pharmadispatch.com/news/final-days-to-help-build-australias-longest-running-life-sciences-benchmark-survey 2025-07-16T04:29:01+10:00 https://pharmadispatch.com/news/noxopharm-confirms-first-patient-dosed-in-sof-skn-heracles-trial 2025-07-16T19:45:01+10:00 https://pharmadispatch.com/news/lumos-diagnostics-signs-febridx-us-distribution-agreement-with-phase-scientific 2025-07-16T20:31:01+10:00 https://pharmadispatch.com/news/ustr-launches-new-investigation-with-minimal-ambition-on-pharmaceuticals 2025-07-17T13:00:01+10:00 https://pharmadispatch.com/news/imugene-completes-significant-placement-and-launches-share-purchase-plan 2025-07-16T21:01:01+10:00 https://pharmadispatch.com/news/cancer-australia-launches-research-program-targeting-early-onset-cancers 2025-07-16T21:21:01+10:00 https://pharmadispatch.com/news/ndis-keeps-growing-but-signs-emerge-that-reforms-are-starting-to-work 2025-07-17T13:00:01+10:00 https://pharmadispatch.com/news/new-zealand-starting-to-benefit-after-lifting-advertising-prohibition 2025-07-17T13:00:01+10:00 https://pharmadispatch.com/news/brandon-biocatalyst-welcomes-the-inclusion-of-its-cureator-in-new-program 2025-07-17T00:07:01+10:00 https://pharmadispatch.com/news/mark-butler-restates-support-for-health-technology-assessment-reform 2025-07-17T02:24:01+10:00 https://pharmadispatch.com/news/another-day-another-confusing-response-to-the-threat-of-us-tariffs 2025-07-17T19:55:01+10:00 https://pharmadispatch.com/news/australian-researcher-awarded-gilead-sciences-global-grant-to-explore-novel-approach-in-breast-c 2025-07-18T13:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-17-july 2025-07-18T03:59:01+10:00 https://pharmadispatch.com/news/companies-have-all-the-power-in-this-process-if-they-choose-to-use-it 2025-07-21T13:00:01+10:00 https://pharmadispatch.com/news/ustr-trump-says-countries-will-avoid-tariffs-if-manufacturing-returns-to-the-us 2025-07-21T12:00:01+10:00 https://pharmadispatch.com/news/company-refuses-fda-request-to-halt-distribution-of-gene-therapy 2025-07-20T20:41:01+10:00 https://pharmadispatch.com/news/mesoblast-updates-investors-on-the-succcesful-us-launch-of-cell-therapy 2025-07-20T22:59:01+10:00 https://pharmadispatch.com/news/another-day-and-another-example-of-our-systems-shortcomings 2025-07-21T13:00:01+10:00 https://pharmadispatch.com/news/mark-butler-acknowledges-dubious-relationship-between-the-pbs-and-us-tariffs 2025-07-22T13:00:01+10:00 https://pharmadispatch.com/news/atomo-diagnostics-announces-successful-placement-from-share-purchase-plan-shortfall 2025-07-21T23:30:01+10:00 https://pharmadispatch.com/news/some-of-pharmacs-fiercest-critics-appointed-to-guide-its-reset-program 2025-07-22T13:00:01+10:00 https://pharmadispatch.com/news/osteopore-secures-clearance-for-jawbone-trial-at-princess-alexandra-hospital 2025-07-22T00:28:01+10:00 https://pharmadispatch.com/news/us-leads-the-way-on-cell-and-gene-therapy-with-new-rapid-access-program 2025-07-23T13:00:01+10:00 https://pharmadispatch.com/news/tga-approves-biogen-therapy-for-rare-neurogenerative-disease 2025-07-22T02:13:01+10:00 https://pharmadispatch.com/news/the-edelman-global-trust-and-health-report-reveals-half-of-young-australians-regret-a-health-dec 2025-07-22T13:00:01+10:00 https://pharmadispatch.com/news/neuraxpharm-continues-international-expansion-with-launch-of-australian-affiliate 2025-07-23T13:00:01+10:00 https://pharmadispatch.com/news/sarepta-backs-down-on-fda-demand-to-halt-distribution-of-gene-therapy 2025-07-22T21:42:01+10:00 https://pharmadispatch.com/news/pharmac-minister-asks-for-more-in-new-letter-of-expectations 2025-07-23T13:00:01+10:00 https://pharmadispatch.com/news/viatris-certified-as-a-great-place-to-work-in-australia-and-new-zealand 2025-07-23T13:00:01+10:00 https://pharmadispatch.com/news/latest-trade-agreement-reveals-us-focus-on-resolving-longstanding-issues 2025-07-24T13:00:01+10:00 https://pharmadispatch.com/news/percheron-therapeutics-announces-publication-of-new-preclinical-hmbd-002-data 2025-07-23T20:36:01+10:00 https://pharmadispatch.com/news/amplia-therapeutics-announces-25-million-placement-and-launches-share-purchase-plan 2025-07-23T20:49:01+10:00 https://pharmadispatch.com/news/nyrada-advances-xolatryp-towards-phase-2a-trial-in-cardioprotection 2025-07-23T21:01:01+10:00 https://pharmadispatch.com/news/oncosil-medical-completes-recruitment-in-tripp-ffx-clinical-trial 2025-07-23T21:10:01+10:00 https://pharmadispatch.com/news/senate-committee-appointments-reveal-a-significant-shake-up 2025-07-24T00:23:01+10:00 https://pharmadispatch.com/news/sanofi-to-acquire-vicebio-gaining-rights-to-queensland-discovered-technology 2025-07-24T02:43:01+10:00 https://pharmadispatch.com/news/is-australia-on-the-list-of-nine-countries-to-be-targeted-over-pricing 2025-07-24T22:38:01+10:00 https://pharmadispatch.com/news/fda-invites-submissions-to-new-rapid-review-priority-program 2025-07-25T13:00:01+10:00 https://pharmadispatch.com/news/pharmac-marks-12-month-anniversary-of-funding-boost 2025-07-25T13:00:01+10:00 https://pharmadispatch.com/news/australian-life-sciences-venture-capital-firm-brandon-capital-announces-fund-six-final-close 2025-07-25T00:16:01+10:00 https://pharmadispatch.com/news/accesscr-announces-finalists-in-consumer-partnerships-in-research-awards 2025-07-25T01:42:01+10:00 https://pharmadispatch.com/news/ok-for-north-korea-to-have-a-say-on-our-health-system-but-not-the-us 2025-07-28T13:00:01+10:00 https://pharmadispatch.com/news/leading-stakeholders-call-for-urgency-on-national-genomics-framework 2025-07-28T13:00:01+10:00 https://pharmadispatch.com/news/hepatitis-australia-wants-action-as-new-analysis-reveals-many-still-missing-cures 2025-07-28T13:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-27-july 2025-07-28T03:26:01+10:00 https://pharmadispatch.com/news/us-and-eu-secure-new-trade-agreement-but-more-to-come-on-pharmaceuticals 2025-07-28T19:13:01+10:00 https://pharmadispatch.com/news/clarity-successfully-completes-203-million-institutional-placement 2025-07-28T20:09:01+10:00 https://pharmadispatch.com/news/government-moves-on-general-co-pay-as-safety-gets-further-out-of-reach 2025-07-29T13:00:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-receives-ind-approval-to-initiate-phase-1-study 2025-07-28T22:31:01+10:00 https://pharmadispatch.com/news/world-first-study-uses-dna-to-investigate-who-develops-ms-and-why 2025-07-30T13:00:01+10:00 https://pharmadispatch.com/news/for-these-families-genomics-is-not-a-luxuryits-the-only-viable-path 2025-07-29T13:00:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-reports-positive-topline-data-from-phase-2-trial-of-ath434 2025-07-29T00:50:01+10:00 https://pharmadispatch.com/news/australian-cell-therapy-company-appoints-experienced-executive-as-ceo 2025-07-29T01:06:01+10:00 https://pharmadispatch.com/news/pharmac-quantities-the-wider-societal-benefit-of-treatments-for-chronic-conditions 2025-07-29T01:44:01+10:00 https://pharmadispatch.com/news/a-lot-going-on-behind-the-scene-but-the-industry-so-far-favouring-public-silence 2025-07-30T13:00:01+10:00 https://pharmadispatch.com/news/the-problem-with-the-ministers-statement-is-that-its-entirely-accurate 2025-07-30T13:00:01+10:00 https://pharmadispatch.com/news/no-data-means-no-prospect-of-access-to-trials-or-funded-medicines 2025-07-30T13:00:01+10:00 https://pharmadispatch.com/news/amplia-therapeutics-secures-ethics-approval-for-pancreatic-cancer-trial 2025-07-30T19:44:01+10:00 https://pharmadispatch.com/news/government-admits-general-safety-net-is-significantly-higher-than-comparable-countries 2025-07-31T13:00:01+10:00 https://pharmadispatch.com/news/companies-face-higher-rebate-payments-as-a-result-of-co-pay-reduction 2025-07-31T13:00:01+10:00 https://pharmadispatch.com/news/substantial-us-program-aims-to-address-gaps-in-hepatitis-c-diagnosis-and-cure 2025-07-31T13:00:01+10:00 https://pharmadispatch.com/news/a-not-so-long-list-of-new-medicines-for-the-november-pbac 2025-07-31T13:00:01+10:00 https://pharmadispatch.com/news/study-reveals-growing-benefit-of-lilly-therapy-for-early-symptomatic-alzheimers-disease 2025-08-01T13:00:01+10:00 https://pharmadispatch.com/news/novartis-backs-the-launch-of-a-new-cardiovascular-disease-program 2025-08-01T13:00:01+10:00 https://pharmadispatch.com/news/first-in-new-wave-of-biosimilars-receive-pbs-listings 2025-08-01T13:00:01+10:00 https://pharmadispatch.com/news/arrotex-pharmaceuticals-expands-haematology-oncology-portfolio-through-antengene-partnership 2025-08-01T13:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-and-medicines-australia-celebrate-catalyst-outcomes-and-further-strengthen-industry-c 2025-08-01T13:00:01+10:00 https://pharmadispatch.com/news/sandoz-biosimilars-of-major-osteoporosis-therapy-available-via-the-pbs 2025-08-01T13:00:01+10:00 https://pharmadispatch.com/news/abbvie-therapy-now-available-on-the-pbs-for-treatment-of-advanced-parkinsons 2025-08-01T13:00:01+10:00 https://pharmadispatch.com/news/trump-administration-takes-another-step-in-most-favored-nation-push 2025-08-01T15:07:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-1-august 2025-08-01T21:53:01+10:00 https://pharmadispatch.com/news/new-survey-reveals-australians-want-more-investment-in-the-pbs 2025-08-04T12:00:01+10:00 https://pharmadispatch.com/news/latest-pharmac-decision-shows-up-australias-one-failure-on-critical-vaccine 2025-08-04T12:00:01+10:00 https://pharmadispatch.com/news/major-radiopharmaceutical-patent-case-exits-australias-federal-court 2025-08-04T12:00:01+10:00 https://pharmadispatch.com/news/regeneron-ceo-says-other-countries-need-to-pay-more-and-mfn-will-not-be-easy 2025-08-04T12:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-series-4-episode-22 2025-08-04T01:16:01+10:00 https://pharmadispatch.com/news/novo-nordisk-says-that-without-action-australia-faces-a-sobering-reality-on-life-expectancy 2025-08-05T12:00:01+10:00 https://pharmadispatch.com/news/a-rigged-system-in-which-delays-are-the-intent-not-the-consequence 2025-08-05T12:00:01+10:00 https://pharmadispatch.com/news/chimeric-therapeutics-provides-update-on-chm-cdh17-car-t-clinical-trial 2025-08-04T23:10:01+10:00 https://pharmadispatch.com/news/race-oncology-announces-the-publication-of-bisantrene-clinical-trial 2025-08-05T00:30:01+10:00 https://pharmadispatch.com/news/compumedics-continues-expansion-into-global-pharmaceutical-clinical-trial-market 2025-08-05T00:38:01+10:00 https://pharmadispatch.com/news/tga-halts-the-promotion-of-vitamin-d-for-bone-strength 2025-08-05T02:45:01+10:00 https://pharmadispatch.com/news/gilead-announces-recipients-of-inaugural-glows-grants-for-indigenous-led-hiv-and-hepatitis-proje 2025-08-06T13:00:01+10:00 https://pharmadispatch.com/news/we-do-what-we-say-we-will-do-lead-by-example-and-find-a-way 2025-08-06T00:52:01+10:00 https://pharmadispatch.com/news/arrotex-pharmaceuticals-welcomes-strategic-investment-into-dbg-health 2025-08-06T01:09:01+10:00 https://pharmadispatch.com/news/he-will-be-deeply-missed-by-all-who-had-the-pleasure-of-getting-to-know-him 2025-08-06T13:00:01+10:00 https://pharmadispatch.com/news/pfizer-ceo-albert-bourla-says-mfn-and-discussions-are-extremely-productive 2025-08-07T13:00:01+10:00 https://pharmadispatch.com/news/medicines-nz-says-new-poll-underscores-the-need-for-urgent-action-on-medicines-access 2025-08-06T23:40:01+10:00 https://pharmadispatch.com/news/cartherics-unveils-state-of-the-art-cleanroom-facility-for-cell-therapy-manufacturing 2025-08-07T03:29:01+10:00 https://pharmadispatch.com/news/merck-welcomes-new-expert-guidance-on-endocrine-testing-for-children 2025-08-07T03:31:01+10:00 https://pharmadispatch.com/news/mark-butler-says-he-is-very-much-on-the-page-of-ensuring-faster-access-to-medicines 2025-08-08T12:00:01+10:00 https://pharmadispatch.com/news/the-imperative-is-to-fully-understand-the-implications-of-any-change 2025-08-08T14:45:01+10:00 https://pharmadispatch.com/news/historic-research-grant-program-aims-to-halve-breast-cancer-deaths 2025-08-08T14:54:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-8-august 2025-08-08T21:04:01+10:00 https://pharmadispatch.com/news/ai-has-to-be-seen-as-an-opportunity-to-get-medicines-to-patients-faster 2025-08-10T12:00:01+10:00 https://pharmadispatch.com/news/could-the-realities-of-ai-quickly-date-or-even-swamp-the-hta-review-outcomes 2025-08-11T12:00:01+10:00 https://pharmadispatch.com/news/neuren-expands-nnz-2591-pipeline-to-include-syngap1-related-disorder 2025-08-11T02:04:01+10:00 https://pharmadispatch.com/news/pyc-therapeutics-accelerates-clinical-progress-of-pyc-003-in-pkd-trial 2025-08-11T02:08:01+10:00 https://pharmadispatch.com/news/we-asked-chatgpt-to-produce-a-podcast-script-about-the-pros-and-cons-of-the-hta-review 2025-08-11T02:43:01+10:00 https://pharmadispatch.com/news/noxopharm-advances-heracles-trial-for-novel-autoimmune-disease-drug 2025-08-11T20:05:01+10:00 https://pharmadispatch.com/news/syntara-receives-fda-guidance-for-amsulostat-in-myelofibrosis-treatment 2025-08-11T20:18:01+10:00 https://pharmadispatch.com/news/if-the-cost-of-this-process-is-truly-rising-at-this-rate-then-the-process-must-be-the-problem 2025-08-12T12:00:01+10:00 https://pharmadispatch.com/news/biogen-announces-leadership-transition-for-australia-and-new-zealand 2025-08-12T12:00:01+10:00 https://pharmadispatch.com/news/pharmac-announces-plan-to-update-access-and-supply-of-covid-19-treatments 2025-08-12T12:00:01+10:00 https://pharmadispatch.com/news/australia-is-not-alone-in-tripping-over-reform-of-medical-device-funding-frameworks 2025-08-12T22:01:01+10:00 https://pharmadispatch.com/news/government-review-and-action-timelines-are-in-dog-years-compared-to-ai 2025-08-13T12:00:01+10:00 https://pharmadispatch.com/news/experienced-innovation-leader-joins-ausbiotech-as-its-head-of-investment 2025-08-13T15:00:01+10:00 https://pharmadispatch.com/news/just-because-the-system-involves-humans-does-not-make-it-human 2025-08-14T12:32:01+10:00 https://pharmadispatch.com/news/avita-medical-successfully-completes-australian-equity-raise 2025-08-13T20:55:01+10:00 https://pharmadispatch.com/news/orthocell-advances-us-rollout-of-nerve-repair-product-remplir 2025-08-13T21:16:01+10:00 https://pharmadispatch.com/news/firebrick-says-nasodine-covid-19-patent-accepted-in-europe 2025-08-13T21:41:01+10:00 https://pharmadispatch.com/news/accesscrs-awards-celebrate-partnerships-between-lived-experience-and-science 2025-08-14T02:04:01+10:00 https://pharmadispatch.com/news/australian-company-mirugen-secures-backing-to-process-cell-technology 2025-08-14T02:47:01+10:00 https://pharmadispatch.com/news/when-it-comes-to-pbac-outcomes-its-all-in-the-language-about-pricing 2025-08-15T13:00:01+10:00 https://pharmadispatch.com/news/nobody-can-possibly-sustain-an-argument-this-is-not-a-price-negotiation 2025-08-15T13:00:01+10:00 https://pharmadispatch.com/news/interim-report-calls-for-prevention-focus-to-boost-the-nations-productivity 2025-08-15T02:19:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-15-august 2025-08-15T22:20:01+10:00 https://pharmadispatch.com/news/from-caution-to-complexity-pbacs-decade-long-changing-language-on-pricing-and-access 2025-08-18T13:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-menarini-in-australia-and-new-zealand 2025-08-18T12:00:01+10:00 https://pharmadispatch.com/news/beigene-launches-its-new-name-and-brand-identity-in-australia-and-new-zealand 2025-08-18T12:00:01+10:00 https://pharmadispatch.com/news/healthengine-launches-an-ai-receptionist-supporting-gp-clinics-and-patients 2025-08-17T23:02:01+10:00 https://pharmadispatch.com/news/bionsw-catalyst-dinner-strengthens-connections-and-investment-in-nsw-life-sciences 2025-08-17T23:20:01+10:00 https://pharmadispatch.com/news/new-crispr-technique-could-rewrite-future-of-genetic-disease-treatment 2025-08-17T23:26:01+10:00 https://pharmadispatch.com/news/lilly-announcement-confirms-the-complexity-of-aligning-prices 2025-08-18T12:00:01+10:00 https://pharmadispatch.com/news/fda-review-timeline-extended-for-neurizons-nuz-001-ind-clinical-hold 2025-08-18T01:53:01+10:00 https://pharmadispatch.com/news/emvision-awarded-non-diluting-grant-for-emu-regional-benefits-study 2025-08-18T02:02:01+10:00 https://pharmadispatch.com/news/novo-nordisk-launches-global-first-marie-krogh-young-women-in-science-prize-in-australia 2025-08-18T13:00:01+10:00 https://pharmadispatch.com/news/should-keep-these-processes-separate-until-the-minister-has-determined-the-outcome 2025-08-19T04:00:01+10:00 https://pharmadispatch.com/news/lilly-launches-new-initiative-with-monash-university-to-improve-gaps-in-obesity-management 2025-08-19T04:00:01+10:00 https://pharmadispatch.com/news/new-zealand-might-be-leading-australia-on-ai-in-medicines-evaluation-and-assessment 2025-08-19T04:00:01+10:00 https://pharmadispatch.com/news/novartis-unveils-new-solution-to-simplify-hcp-access-to-private-prescriptions 2025-08-19T01:15:01+10:00 https://pharmadispatch.com/news/ai-added-to-the-work-of-hta-review-implementation-advisory-group 2025-08-20T13:00:01+10:00 https://pharmadispatch.com/news/csl-launches-strategic-initiative-with-planned-spinout-of-seqirus 2025-08-20T13:00:01+10:00 https://pharmadispatch.com/news/former-queensland-premier-appointed-to-chair-brandon-biocatalyst 2025-08-20T03:06:01+10:00 https://pharmadispatch.com/news/draft-nice-guidance-proposes-major-shake-up-of-uk-diabetes-treatment 2025-08-21T12:00:01+10:00 https://pharmadispatch.com/news/we-dont-need-new-laws-for-conditional-outcomes-because-they-are-already-embedded-in-the-system 2025-08-21T12:00:01+10:00 https://pharmadispatch.com/news/us-fda-grants-orphan-drug-designation-to-invions-inv043 2025-08-20T23:16:01+10:00 https://pharmadispatch.com/news/neurizons-nuz-001-ole-study-demonstrates-long-term-safety-and-efficacy-signals 2025-08-20T23:22:01+10:00 https://pharmadispatch.com/news/ltr-pharma-says-new-study-confirms-faster-onset-of-intranasal-treatment 2025-08-20T23:28:01+10:00 https://pharmadispatch.com/news/the-pbacs-conditionality-and-provisional-revolution-from-2013-to-2024 2025-08-21T12:00:01+10:00 https://pharmadispatch.com/news/if-companies-accept-conditional-recommendations-they-will-keep-imposing-them 2025-08-22T12:00:01+10:00 https://pharmadispatch.com/news/seymour-welcomes-medsafe-year-on-year-improvement 2025-08-21T23:33:01+10:00 https://pharmadispatch.com/news/applications-now-open-for-ausbiotech-invest-and-the-early-stage-innovation-forum 2025-08-22T04:26:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-22-august 2025-08-22T22:07:01+10:00 https://pharmadispatch.com/news/pbac-delivers-recommendations-dominated-by-price-cuts-and-risk-shares 2025-08-25T12:00:01+10:00 https://pharmadispatch.com/news/an-outcome-that-might-haunt-the-systems-decision-making-like-banquos-ghost 2025-08-25T12:00:01+10:00 https://pharmadispatch.com/news/disappointment-as-committee-stalls-again-on-broad-listing-for-cancer-immunotherapies 2025-08-25T12:00:01+10:00 https://pharmadispatch.com/news/girls-to-graduates-program-event-in-partnership-with-astrazeneca 2025-08-24T22:31:01+10:00 https://pharmadispatch.com/news/world-first-clinical-trial-reveals-unprecedented-insights-into-brain-cancer-treatment 2025-08-24T22:39:01+10:00 https://pharmadispatch.com/news/argent-biopharma-announces-results-of-independent-in-vivo-study 2025-08-25T20:06:01+10:00 https://pharmadispatch.com/news/first-site-initiated-for-neurens-phelan-mcdermid-syndrome-phase-3-trial 2025-08-25T20:31:01+10:00 https://pharmadispatch.com/news/botanix-appoints-dr-patricia-walker-as-a-non-executive-director 2025-08-25T20:43:01+10:00 https://pharmadispatch.com/news/uk-industry-cites-us-pricing-ambitions-in-collapse-of-new-agreement-negotiation 2025-08-25T20:57:01+10:00 https://pharmadispatch.com/news/the-next-negotiation-was-always-going-to-be-complicated-the-new-reality-will-makes-it-more-so 2025-08-25T21:54:01+10:00 https://pharmadispatch.com/news/patients-cant-wait-swift-action-and-access-are-the-only-possible-moves-from-here 2025-08-26T12:00:01+10:00 https://pharmadispatch.com/news/bayer-partners-with-arrotex-to-strengthen-access-to-oral-contraceptives 2025-08-26T02:45:01+10:00 https://pharmadispatch.com/news/vaxxas-secures-90-million-in-funding-to-commercialise-needle-free-vaccination-delivery-technolog 2025-08-26T03:19:01+10:00 https://pharmadispatch.com/news/australians-rapidly-increasing-their-embrace-of-ai-including-for-healthcare 2025-08-26T21:17:01+10:00 https://pharmadispatch.com/news/mark-butler-asking-questions-about-trumps-most-favored-nation-pricing-push 2025-08-27T12:00:01+10:00 https://pharmadispatch.com/news/bristol-myers-squibb-launches-cancer-resources-for-first-nations-australians 2025-08-27T12:00:01+10:00 https://pharmadispatch.com/news/gbma-appoints-teva-regional-director-stephen-jenkins-to-its-board-of-directors 2025-08-27T01:23:01+10:00 https://pharmadispatch.com/news/government-and-coalition-combine-to-defeat-moderna-agreement-motion 2025-08-27T02:30:01+10:00 https://pharmadispatch.com/news/sigma-healthcare-delivers-strong-first-year-results-after-chemist-warehouse-merger 2025-08-27T19:02:01+10:00 https://pharmadispatch.com/news/neuren-doubles-profit-as-daybue-royalties-and-pipeline-progress-drive-growth 2025-08-27T19:54:01+10:00 https://pharmadispatch.com/news/biome-achieves-breakthrough-year-with-first-profit-and-rapid-global-expansion 2025-08-27T20:07:01+10:00 https://pharmadispatch.com/news/starpharma-advances-dendrimer-platform-with-clinical-commercial-and-strategic-progress 2025-08-27T20:21:01+10:00 https://pharmadispatch.com/news/neuroscientifics-stemsmart-msc-therapy-shows-promise-in-kidney-transplantation 2025-08-27T20:33:01+10:00 https://pharmadispatch.com/news/cartherics-secures-chinese-patent-to-boost-immune-cell-function-in-solid-tumours 2025-08-27T21:13:01+10:00 https://pharmadispatch.com/news/sandoz-pushes-for-biosimilar-reform-while-building-a-great-workplace 2025-08-27T21:19:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-showcases-more-accessible-healthcare-for-women 2025-08-27T22:10:01+10:00 https://pharmadispatch.com/news/coalition-turns-debate-on-cheaper-medicines-bill-to-hta-reform-delays 2025-08-28T02:48:01+10:00 https://pharmadispatch.com/news/ndis-quarterly-report-presents-a-positive-picture-but-questions-remain 2025-08-29T12:00:01+10:00 https://pharmadispatch.com/news/wesfarmers-health-delivers-growth-as-priceline-drives-consumer-momentum 2025-08-29T12:00:01+10:00 https://pharmadispatch.com/news/government-pressed-on-diabetes-inquiry-response-as-obesity-costs-hit-12-billion-a-year 2025-08-29T12:00:01+10:00 https://pharmadispatch.com/news/you-can-ignore-reality-but-you-cant-ignore-the-consequences-of-ignoring-reality 2025-08-29T12:00:01+10:00 https://pharmadispatch.com/news/australians-fear-the-loss-of-independence-as-vision-health-concerns-rise 2025-08-29T12:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-29-august 2025-08-29T23:18:01+10:00 https://pharmadispatch.com/news/new-pbs-listing-brings-relief-for-children-with-severe-asthma 2025-09-01T10:00:01+10:00 https://pharmadispatch.com/news/australia-expands-childhood-protection-with-new-20-valent-pneumococcal-vaccine 2025-09-01T10:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-draft-national-health-and-medical-research-strategy 2025-09-01T10:00:01+10:00 https://pharmadispatch.com/news/patients-say-governments-rare-cancer-inquiry-response-falls-short-of-needed-action 2025-09-01T10:00:01+10:00 https://pharmadispatch.com/news/pbac-to-have-another-attempt-at-broad-immunotherapy-listing 2025-09-01T10:00:01+10:00 https://pharmadispatch.com/news/csls-rd-struggles-at-home-are-a-warning-australia-cannot-ignore 2025-09-02T12:00:01+10:00 https://pharmadispatch.com/news/new-report-finds-rare-cancer-patients-face-inequities-long-before-diagnosis 2025-09-01T10:00:01+10:00 https://pharmadispatch.com/news/private-health-insurance-rebate-saves-more-than-it-costs-but-its-value-is-slipping-away 2025-09-01T10:00:01+10:00 https://pharmadispatch.com/news/judge-the-outcome-by-its-impact-not-by-the-promises-made-this-week 2025-09-02T12:00:01+10:00 https://pharmadispatch.com/news/adherium-pushes-ahead-with-us-expansion-and-stronger-commercial-focus 2025-09-01T01:11:01+10:00 https://pharmadispatch.com/news/neurotech-advances-nti164-with-strong-clinical-data-and-new-leadership 2025-09-01T01:12:01+10:00 https://pharmadispatch.com/news/oncosil-secures-regulatory-wins-and-expands-global-footprint-in-2025 2025-09-01T01:13:01+10:00 https://pharmadispatch.com/news/prescient-secures-investor-support-to-advance-ptx-100-in-cancer-trials 2025-09-01T01:13:01+10:00 https://pharmadispatch.com/news/island-pharmaceuticals-reports-clinical-progress-and-expanded-pipeline 2025-09-01T01:14:01+10:00 https://pharmadispatch.com/news/immuron-confirms-record-sales-and-major-clinical-milestones 2025-09-01T01:15:01+10:00 https://pharmadispatch.com/news/pbs-expansion-delivers-earlier-access-to-vertex-cystic-fibrosis-therapy 2025-09-01T10:00:01+10:00 https://pharmadispatch.com/news/landmark-vaccination-program-protected-140000-australian-babies-this-winter 2025-09-01T20:36:01+10:00 https://pharmadispatch.com/news/arthritis-australia-marks-75-years-with-call-to-end-old-age-myths 2025-09-01T20:52:01+10:00 https://pharmadispatch.com/news/pharmac-secures-ongoing-supply-of-pfizers-covid-19-vaccine 2025-09-01T23:12:01+10:00 https://pharmadispatch.com/news/political-leaders-clash-and-converge-on-medicines-access-and-hta-reform 2025-09-02T22:16:01+10:00 https://pharmadispatch.com/news/inspiring-the-next-generation-girls-in-stem-step-into-the-future-of-health 2025-09-02T22:24:01+10:00 https://pharmadispatch.com/news/merck-recognised-during-womens-health-week 2025-09-02T22:29:01+10:00 https://pharmadispatch.com/news/when-it-comes-to-genomics-and-healthcare-australia-lags-the-uks-ambition 2025-09-03T00:42:01+10:00 https://pharmadispatch.com/news/novartis-announces-leadership-transition-in-australia-and-new-zealand 2025-09-03T06:08:01+10:00 https://pharmadispatch.com/news/blair-comley-says-ai-and-digital-the-future-of-australian-healthcare 2025-09-03T21:34:01+10:00 https://pharmadispatch.com/news/regulate-the-regulators-why-ndis-audit-fees-are-failing-providers-and-participants 2025-09-04T01:11:01+10:00 https://pharmadispatch.com/news/stakeholders-could-be-mistaken-for-thinking-the-process-is-the-point 2025-09-04T06:25:01+10:00 https://pharmadispatch.com/news/the-latest-hta-review-report-is-museum-piece-on-policymaking-and-reform 2025-09-04T06:56:01+10:00 https://pharmadispatch.com/news/the-review-is-being-squeezed-dry-like-juice-from-a-lemon-and-patients-might-only-get-the-rind 2025-09-04T21:58:01+10:00 https://pharmadispatch.com/news/australian-industry-looks-to-the-uk-as-likely-lessons-for-us-most-favored-nation 2025-09-05T02:57:01+10:00 https://pharmadispatch.com/news/novartis-anz-appoints-marco-muscardo-as-ad-interim-country-president 2025-09-05T03:22:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-5-september 2025-09-05T21:15:01+10:00 https://pharmadispatch.com/news/comley-letter-outlines-health-departments-regulatory-reform-agenda 2025-09-08T10:00:01+10:00 https://pharmadispatch.com/news/why-put-an-explicit-target-on-ai-accelerating-regulatory-reviews-but-not-hta 2025-09-08T10:00:01+10:00 https://pharmadispatch.com/news/world-leading-virologist-recognised-for-pioneering-ai-based-infectious-disease-detection-technol 2025-09-08T10:00:01+10:00 https://pharmadispatch.com/news/without-a-major-shift-in-direction-this-new-review-will-deliver-very-little-change 2025-09-08T10:00:01+10:00 https://pharmadispatch.com/news/clinuvel-charts-a-profitable-pathway-amid-sector-volatility 2025-09-07T21:55:01+10:00 https://pharmadispatch.com/news/botanix-announces-regulatory-approval-of-ecclock-in-south-korea 2025-09-07T22:27:01+10:00 https://pharmadispatch.com/news/real-world-data-shows-significant-reduction-in-hospital-stay-using-avita-medicals-recell 2025-09-07T22:32:01+10:00 https://pharmadispatch.com/news/promarkereso-blood-test-detects-early-stages-of-esophageal-adenocarcinoma-with-high-accuracy 2025-09-08T19:03:01+10:00 https://pharmadispatch.com/news/orthocell-says-remplir-study-delivers-compelling-success-rate 2025-09-08T19:27:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-raises-20-million-in-strategic-placement 2025-09-08T20:07:01+10:00 https://pharmadispatch.com/news/mayne-pharma-responds-to-reports-on-the-future-of-adelaide-manufacturing-site 2025-09-08T22:43:01+10:00 https://pharmadispatch.com/news/fda-unveils-landmark-pathway-in-latest-push-to-accelerate-rare-disease-drug-approvals 2025-09-08T22:59:01+10:00 https://pharmadispatch.com/news/ip-australia-flags-streamlined-patent-opposition-process-in-pharmaceutical-sector 2025-09-09T00:41:01+10:00 https://pharmadispatch.com/news/roche-links-health-to-sustainability-in-new-report 2025-09-10T13:00:01+10:00 https://pharmadispatch.com/news/final-trailblazers-episode-highlights-lessons-from-the-pandemic-and-the-future-of-health-policy 2025-09-09T22:42:01+10:00 https://pharmadispatch.com/news/pathkeys-ai-shows-promise-in-predicting-clinical-trial-success 2025-09-10T01:52:01+10:00 https://pharmadispatch.com/news/cancer-leaders-unite-to-tackle-equity-and-innovation-at-2025-pcpa-summit 2025-09-11T03:58:01+10:00 https://pharmadispatch.com/news/chemist-warehouse-partners-with-doordash-to-deliver-health-and-beauty-on-demand 2025-09-11T04:16:01+10:00 https://pharmadispatch.com/news/trump-administrationannounces-new-disclosure-rules-for-medicine-advertising 2025-09-11T04:20:01+10:00 https://pharmadispatch.com/news/australian-biotechs-shine-at-asia-pacific-cell-and-gene-therapy-awards 2025-09-11T20:54:01+10:00 https://pharmadispatch.com/news/artificial-intelligence-can-only-accelerate-health-technology-assessments 2025-09-11T21:34:01+10:00 https://pharmadispatch.com/news/surely-this-is-what-the-collapse-of-moral-authority-looks-like 2025-09-12T01:32:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-12-september 2025-09-12T22:19:01+10:00 https://pharmadispatch.com/news/pbac-chair-calls-for-flexibility-on-fixed-17-week-evaluation-timeframe 2025-09-14T22:03:01+10:00 https://pharmadispatch.com/news/is-this-the-sign-that-australias-hta-system-become-too-complex-for-its-own-good 2025-09-15T11:00:01+10:00 https://pharmadispatch.com/news/albania-appoints-ai-generated-minister-to-oversee-public-procurement 2025-09-15T11:00:01+10:00 https://pharmadispatch.com/news/avita-medical-receives-ce-mark-for-recell-go-enabling-commercialisation-across-europe 2025-09-15T20:06:01+10:00 https://pharmadispatch.com/news/lilly-australia-announces-leadership-transition-as-tori-brown-moves-to-global-role 2025-09-16T13:00:01+10:00 https://pharmadispatch.com/news/new-roadmap-launched-to-support-australians-living-with-aggressive-lymphomas 2025-09-22T13:00:01+10:00 https://pharmadispatch.com/news/adheriums-smartinhaler-shows-breakthrough-results-in-real-world-respiratory-study 2025-09-15T20:42:01+10:00 https://pharmadispatch.com/news/cleo-diagnostics-gains-positive-fda-feedback-guiding-us-approval-for-ovarian-cancer-test 2025-09-15T20:55:01+10:00 https://pharmadispatch.com/news/actinogen-secures-fda-agreement-to-advance-xanamem-for-alzheimers-disease 2025-09-15T21:01:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-delivers-promising-phase-2-data-in-multiple-system-atrophy 2025-09-15T21:46:01+10:00 https://pharmadispatch.com/news/decision-making-at-its-nadir-exposing-the-cruelty-of-incoherence 2025-09-16T13:00:01+10:00 https://pharmadispatch.com/news/australian-discovery-advances-to-global-phase-3-breast-cancer-trial-with-pfizer 2025-09-16T01:16:01+10:00 https://pharmadispatch.com/news/use-of-psychotics-twice-as-high-in-aged-care-residents-with-dementia 2025-09-16T01:40:01+10:00 https://pharmadispatch.com/news/if-this-makes-you-uncomfortable-it-should-because-it-is-the-only-correct-response 2025-09-16T20:32:01+10:00 https://pharmadispatch.com/news/csl-partners-with-varmx-on-first-in-class-coagulation-treatment 2025-09-16T21:09:01+10:00 https://pharmadispatch.com/news/new-data-reveals-deep-inequities-as-sanofi-rolls-out-trust-building-initiative 2025-09-17T12:00:01+10:00 https://pharmadispatch.com/news/adelaide-to-host-dhls-next-generation-transport-and-warehousing-facility 2025-09-16T21:16:01+10:00 https://pharmadispatch.com/news/new-mental-health-service-takes-aim-at-the-silent-struggle-of-undiagnosed-adhd 2025-09-16T21:20:01+10:00 https://pharmadispatch.com/news/merck-welcomes-new-director-of-market-access-government-affairs-and-communications 2025-09-17T03:37:01+10:00 https://pharmadispatch.com/news/ipsen-appoints-dagmar-tschoep-as-general-manager-for-australia-and-new-zealand 2025-09-17T03:42:01+10:00 https://pharmadispatch.com/news/pharmac-proposes-funding-new-adhd-medicine-to-tackle-supply-shortages 2025-09-17T21:05:01+10:00 https://pharmadispatch.com/news/australian-dementia-network-registry-looking-to-drive-innovation-in-care 2025-09-17T21:18:01+10:00 https://pharmadispatch.com/news/island-pharmaceuticals-reports-breakthrough-survival-data-for-galidesivir-in-marburg-and-ebola-s 2025-09-18T03:50:01+10:00 https://pharmadispatch.com/news/mark-butler-acknowledges-his-concerns-over-potential-impact-of-us-pharmaceutical-pricing-reforms 2025-09-19T11:00:01+10:00 https://pharmadispatch.com/news/sanofi-promotes-a-national-dialogue-on-health-literacy-and-trust 2025-09-18T21:58:01+10:00 https://pharmadispatch.com/news/if-the-minister-it-too-embarrassed-to-respond-it-might-be-the-right-response 2025-09-19T11:00:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-of-australia-acquires-member-benefits-australia 2025-09-19T02:18:01+10:00 https://pharmadispatch.com/news/csl-appoints-new-global-head-of-search-to-accelerate-innovation-through-strategic-partnerships 2025-09-19T04:13:01+10:00 https://pharmadispatch.com/news/national-talks-aim-to-address-rare-cancer-trial-inequities 2025-09-22T13:00:01+10:00 https://pharmadispatch.com/news/sanofi-australia-makes-the-bold-leap-to-sydeys-barangaroo 2025-09-22T13:00:01+10:00 https://pharmadispatch.com/news/australia-must-choose-its-path-abbvies-pierre-claude-fumoleau-on-access-and-innovation-in-health 2025-09-22T12:00:01+10:00 https://pharmadispatch.com/news/women-often-left-to-manage-migraines-without-support-study-finds 2025-09-22T13:00:01+10:00 https://pharmadispatch.com/news/proteomics-international-secures-key-laboratory-certification-in-boost-for-precision-diagnostics 2025-09-21T20:36:01+10:00 https://pharmadispatch.com/news/island-pharmaceuticals-secures-fda-backing-for-next-steps-on-marburg-antiviral 2025-09-21T21:11:01+10:00 https://pharmadispatch.com/news/australian-blood-test-offers-breakthrough-in-detecting-deadly-esophageal-cancer 2025-09-21T21:19:01+10:00 https://pharmadispatch.com/news/clinuvels-scenesse-demonstrates-promising-results-in-vitiligo-patients 2025-09-21T21:26:01+10:00 https://pharmadispatch.com/news/medicines-australia-opens-ballot-for-board-elections 2025-09-22T15:11:01+10:00 https://pharmadispatch.com/news/doctors-urge-australians-to-check-their-pulse-as-af-awareness-week-begins 2025-09-22T19:13:01+10:00 https://pharmadispatch.com/news/ltr-pharma-expands-into-sustainable-omega-3-with-strategic-stake-in-levomega 2025-09-22T20:01:01+10:00 https://pharmadispatch.com/news/starpharma-strikes-landmark-cancer-therapy-deal-with-genentech 2025-09-22T20:04:01+10:00 https://pharmadispatch.com/news/157-million-in-cureator-funding-boosts-australian-startups-tackling-dementia 2025-09-22T20:07:01+10:00 https://pharmadispatch.com/news/australias-first-mrna-facility-promises-jobs-growth-and-health-security 2025-09-23T13:00:01+10:00 https://pharmadispatch.com/news/familiar-name-appointed-to-lead-the-national-blood-authority 2025-09-24T13:00:01+10:00 https://pharmadispatch.com/news/tga-reports-progress-on-gmp-clearance-backlog-strategy 2025-09-23T22:54:01+10:00 https://pharmadispatch.com/news/percheron-strengthens-leadership-team-ahead-of-next-trial-for-hmbd-002 2025-09-23T23:02:01+10:00 https://pharmadispatch.com/news/medicines-australia-and-government-jointly-assessing-the-impact-of-mfn 2025-09-24T13:00:01+10:00 https://pharmadispatch.com/news/clinicians-urge-reform-of-pbs-restrictions-for-pulmonary-arterial-hypertension 2025-09-23T23:31:01+10:00 https://pharmadispatch.com/news/where-did-that-come-from-and-why-are-they-saying-this-out-loud 2025-09-24T02:03:01+10:00 https://pharmadispatch.com/news/arovella-showcases-inkt-cell-therapy-platform-at-asx-smidcaps-conference 2025-09-24T19:21:01+10:00 https://pharmadispatch.com/news/race-oncology-secures-ind-approval-in-korea-for-rc220 2025-09-24T19:27:01+10:00 https://pharmadispatch.com/news/atomos-expands-debt-facility-to-support-strategic-growth 2025-09-24T19:33:01+10:00 https://pharmadispatch.com/news/bupa-launches-free-pharmacogenomics-program-to-support-safer-more-effective-medicine-use 2025-09-24T19:42:01+10:00 https://pharmadispatch.com/news/inoviqs-car-nk-exosomes-show-potent-tumour-killing-effect-in-breast-cancer-study 2025-09-24T20:00:01+10:00 https://pharmadispatch.com/news/pharmac-proposes-funding-roche-medicines-under-multi-product-agreement 2025-09-24T20:11:01+10:00 https://pharmadispatch.com/news/wehi-researchers-unlock-the-immune-systems-instruction-manual 2025-09-24T20:31:01+10:00 https://pharmadispatch.com/news/painaustralia-backs-tga-reassurance-on-paracetamol-safety-in-pregnancy 2025-09-24T23:25:01+10:00 https://pharmadispatch.com/news/tga-approves-eisai-biogen-therapy-for-alzheimers-disease 2025-09-25T01:09:01+10:00 https://pharmadispatch.com/news/real-world-evidence-shows-lumos-diagnostics-febridx-cuts-antibiotic-use-and-delivers-system-savi 2025-09-25T02:00:01+10:00 https://pharmadispatch.com/news/australians-missing-out-on-faster-care-by-underusing-community-pharmacists 2025-09-25T14:49:01+10:00 https://pharmadispatch.com/news/waiting-for-any-impact-why-the-albanese-government-will-hold-fire-on-mfn 2025-09-26T13:00:01+10:00 https://pharmadispatch.com/news/recce-pharmaceuticals-begins-patient-dosing-in-pivotal-diabetic-foot-infection-trial 2025-09-25T20:30:01+10:00 https://pharmadispatch.com/news/federal-minister-to-address-ausbiotech-international-conference-as-sector-marks-critical-junctur 2025-09-25T21:04:01+10:00 https://pharmadispatch.com/news/gene-therapy-shows-early-promise-in-slowing-huntingtons-disease 2025-09-25T21:55:01+10:00 https://pharmadispatch.com/news/tga-consulting-on-the-ongoing-need-for-paper-product-information-inserts 2025-09-25T23:03:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-pushes-for-patient-voices-to-lead-policy-reform 2025-09-26T13:00:01+10:00 https://pharmadispatch.com/news/juvenile-arthritis-foundation-australia-named-small-charity-of-the-year 2025-09-26T19:59:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-26-september 2025-09-26T22:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-australia-launches-new-education-hub-with-focus-on-gynaecological-cancers 2025-09-27T19:32:01+10:00 https://pharmadispatch.com/news/is-the-institution-able-to-change-in-response-to-something-it-may-not-be-capable-of-recognising 2025-09-29T01:00:01+10:00 https://pharmadispatch.com/news/pfizer-says-no-to-recommendation-for-dermatitis-therapy 2025-09-29T04:00:01+10:00 https://pharmadispatch.com/news/mark-butler-announces-pbs-listings-for-1-october 2025-09-28T21:01:01+10:00 https://pharmadispatch.com/news/the-symptoms-have-been-identified-but-the-widely-held-belief-about-the-cause-is-a-miss 2025-09-30T12:00:01+10:00 https://pharmadispatch.com/news/chimeric-reports-encouraging-early-data-from-chm-cdh17-trial 2025-09-29T20:50:01+10:00 https://pharmadispatch.com/news/lower-than-expected-uptake-of-new-therapies-impacts-pbs-spend 2025-09-29T23:11:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-targets-major-market-with-ath434-in-multiple-system-atrophy 2025-09-29T23:30:01+10:00 https://pharmadispatch.com/news/clinuvel-advances-next-generation-peptide-drug-formulations 2025-09-29T23:43:01+10:00 https://pharmadispatch.com/news/anatara-strengthens-board-with-the-appointment-of-dirk-van-dissel 2025-09-29T23:50:01+10:00 https://pharmadispatch.com/news/uk-companies-are-granted-more-time-to-decide-on-pricing-agreement 2025-09-30T01:28:01+10:00 https://pharmadispatch.com/news/reforming-the-institutional-framework-is-the-only-pathway-to-fairness 2025-10-01T03:00:01+10:00 https://pharmadispatch.com/news/melbourne-clinic-pioneers-integration-of-altered-state-therapies-in-mental-health-care 2025-09-30T21:53:01+10:00 https://pharmadispatch.com/news/new-pricing-dynamics-emerge-for-australian-in-response-to-mfn 2025-10-01T10:00:01+10:00 https://pharmadispatch.com/news/strengthening-medical-affairs-with-a-new-competency-framework 2025-10-01T12:00:01+10:00 https://pharmadispatch.com/news/is-a-new-listing-another-test-for-pbs-biosimilar-policy 2025-10-01T13:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-and-medicines-australia-launch-new-advisory-group-to-accelerate-advanced-therapies 2025-10-01T12:00:01+10:00 https://pharmadispatch.com/news/if-the-uk-has-blinked-on-pharmaceutical-pricing-australia-might-have-to-pay-attention 2025-10-02T13:00:01+10:00 https://pharmadispatch.com/news/trump-signs-executive-order-to-harness-ai-in-the-fight-against-paediatric-cancer 2025-10-01T20:13:01+10:00 https://pharmadispatch.com/news/cancer-vaccine-collaboration-lands-on-the-gold-coast 2025-10-01T20:25:01+10:00 https://pharmadispatch.com/news/inoviq-publishes-breakthrough-data-on-next-generation-cancer-therapy 2025-10-01T21:20:01+10:00 https://pharmadispatch.com/news/new-zealand-resets-medical-device-procurement-after-years-of-paralysis 2025-10-01T21:27:01+10:00 https://pharmadispatch.com/news/dorsavi-achieves-breakthrough-in-robotic-reflex-intelligence 2025-10-01T21:33:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-accelerates-her2-cancer-trial-after-positive-safety-review 2025-10-01T21:37:01+10:00 https://pharmadispatch.com/news/rising-influenza-deaths-spark-call-for-nurse-led-vaccination-clinics 2025-10-01T22:19:01+10:00 https://pharmadispatch.com/news/the-challenge-is-for-our-gatekeepers-can-they-see-beyond-the-gate 2025-10-03T12:00:01+10:00 https://pharmadispatch.com/news/pharmac-moves-to-ease-access-to-hiv-medicines-in-new-zealand 2025-10-02T21:05:01+10:00 https://pharmadispatch.com/news/trump-administration-links-mfn-and-lower-prices-to-faster-fda-approvals 2025-10-03T12:00:01+10:00 https://pharmadispatch.com/news/mark-butler-announces-boost-for-clinical-trial-reform-after-years-of-delay 2025-10-02T22:17:01+10:00 https://pharmadispatch.com/news/race-oncology-uncovers-novel-anticancer-mechanism-for-bisantrene 2025-10-03T01:50:01+10:00 https://pharmadispatch.com/news/vertex-appoints-elisha-whitfield-as-senior-country-manager-for-australia-and-new-zealand 2025-10-03T03:33:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-3-october 2025-10-03T23:40:01+10:00 https://pharmadispatch.com/news/the-theology-of-syntax-and-how-hta-exercises-power-through-language 2025-10-07T05:00:01+11:00 https://pharmadispatch.com/news/artrya-share-purchase-plan-closes-early-after-strong-investor-demand 2025-10-05T21:08:01+11:00 https://pharmadispatch.com/news/mesoblast-secures-key-us-reimbursement-milestone-for-ryoncil 2025-10-05T21:22:01+11:00 https://pharmadispatch.com/news/4dmedical-raises-226-million-through-near-total-exercise-of-options 2025-10-05T21:28:01+11:00 https://pharmadispatch.com/news/oncosil-medical-expands-european-reach-with-first-treatment-in-portugal 2025-10-05T21:34:01+11:00 https://pharmadispatch.com/news/ausbiotech-welcomes-136-million-investment-to-strengthen-clinical-trials 2025-10-05T21:45:01+11:00 https://pharmadispatch.com/news/no-need-to-look-very-far-for-examples-of-governance-that-could-bring-fairness-to-hta 2025-10-07T05:00:01+11:00 https://pharmadispatch.com/news/patients-policy-and-productivity-a-call-for-faster-access-to-innovation 2025-10-07T12:00:01+11:00 https://pharmadispatch.com/news/neuroscientific-gains-tga-approval-for-first-patients-in-crohns-disease-program 2025-10-07T21:20:01+11:00 https://pharmadispatch.com/news/fda-clears-clinical-hold-on-neurizons-nuz-001-paving-way-for-healey-als-trial 2025-10-07T21:44:01+11:00 https://pharmadispatch.com/news/new-report-highlights-widening-gap-in-access-to-modern-medicines-between-australia-and-nz 2025-10-08T13:00:01+11:00 https://pharmadispatch.com/news/percheron-therapeutics-reports-positive-final-data-from-early-phase-trial-of-hmbd-002 2025-10-07T23:15:01+11:00 https://pharmadispatch.com/news/mtpconnect-and-wholesale-investor-unite-to-accelerate-investment-in-life-sciences-sector 2025-10-08T01:34:01+11:00 https://pharmadispatch.com/news/astrazeneca-becomes-the-latest-to-say-it-could-halt-uk-investment-over-appalling-pricing-regime 2025-10-08T01:48:01+11:00 https://pharmadispatch.com/news/ausbiotechs-annual-report-highlights-a-defining-year-for-australias-life-sciences-sector 2025-10-08T02:03:01+11:00 https://pharmadispatch.com/news/racgp-warns-of-mounting-pressure-on-gps-as-costs-and-complexity-rise 2025-10-08T02:32:01+11:00 https://pharmadispatch.com/news/cureator-opens-33-million-funding-round-with-csl-and-abbvie-partnership 2025-10-08T21:38:01+11:00 https://pharmadispatch.com/news/pharmaceutical-spending-to-rise-by-around-10-billion-but-still-lose-ground-to-other-programs 2025-10-09T13:00:01+11:00 https://pharmadispatch.com/news/australian-company-reports-positive-outcome-from-collaboration 2025-10-09T04:51:01+11:00 https://pharmadispatch.com/news/officials-outline-ongoing-measures-to-address-adhd-medicine-shortages 2025-10-09T21:14:01+11:00 https://pharmadispatch.com/news/life-sciences-industry-calls-for-stronger-national-strategy-to-support-trials-and-innovation 2025-10-09T23:04:01+11:00 https://pharmadispatch.com/news/ausbiotech-unveils-international-conference-program-for-australias-biggest-week-in-biotech 2025-10-10T03:12:01+11:00 https://pharmadispatch.com/news/this-exchange-on-the-hta-review-was-about-as-underwhelming-as-it-sounds 2025-10-10T09:32:01+11:00 https://pharmadispatch.com/news/astrazeneca-joins-pfizer-in-signing-mfn-pricing-agreement-with-trump-administration 2025-10-12T21:56:01+11:00 https://pharmadispatch.com/news/we-cant-really-moan-about-another-country-doing-what-we-have-been-doing-for-decades 2025-10-12T22:24:01+11:00 https://pharmadispatch.com/news/valuing-life-summit-brings-medicines-access-under-the-spotlight-in-wellington 2025-10-12T23:11:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-12-october 2025-10-12T23:40:01+11:00 https://pharmadispatch.com/news/adherium-launches-early-exercise-incentive-offer-to-reward-optionholders 2025-10-13T18:49:01+11:00 https://pharmadispatch.com/news/artrya-clears-key-us-milestone-for-coronary-device-targets-fda-filing-by-year-end 2025-10-13T18:58:01+11:00 https://pharmadispatch.com/news/medical-developments-international-signals-a-turn-to-growth-as-penthrox-momentum-builds 2025-10-13T19:20:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-readies-pyc-002-for-clinic-after-positive-pre-clinical-data 2025-10-13T21:48:01+11:00 https://pharmadispatch.com/news/of-course-it-will-never-change-if-you-never-make-the-case-for-change 2025-10-13T23:08:01+11:00 https://pharmadispatch.com/news/former-ma-chair-to-chair-the-australian-maker-of-the-green-whistle 2025-10-14T00:55:01+11:00 https://pharmadispatch.com/news/australian-first-for-argenx-with-autoimmune-research-partnership-with-unisa 2025-10-14T01:52:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-unites-with-the-ama-to-urge-change-on-medicinal-cannabis-regulation 2025-10-14T16:09:01+11:00 https://pharmadispatch.com/news/what-seems-positive-from-afar-can-look-very-different-to-those-who-live-it 2025-10-14T22:28:01+11:00 https://pharmadispatch.com/news/cancer-survival-continues-to-rise-but-demand-on-australias-chemotherapy-system-grows 2025-10-15T00:44:01+11:00 https://pharmadispatch.com/news/victorian-government-ministers-to-headline-australias-biggest-biotech-week 2025-10-15T15:21:01+11:00 https://pharmadispatch.com/news/telix-pharmaceuticals-lifts-revenue-guidance-after-strong-third-quarter-performance 2025-10-15T18:48:01+11:00 https://pharmadispatch.com/news/vicki-robinson-joins-proteomics-international-board-as-independent-non-executive-director 2025-10-15T20:29:01+11:00 https://pharmadispatch.com/news/medibank-backs-expansion-of-emyrias-trauma-and-depression-programs-to-queensland 2025-10-15T20:34:01+11:00 https://pharmadispatch.com/news/intranasal-insulin-delivers-new-hope-for-delirium-treatment 2025-10-15T20:37:01+11:00 https://pharmadispatch.com/news/biotron-limited-to-acquire-sedarex-and-raise-25-million-to-accelerate-anaesthetic-program 2025-10-16T01:09:01+11:00 https://pharmadispatch.com/news/chimeric-and-viral-vector-manufacturing-facility-sign-advanced-manufacturing-agreement 2025-10-16T01:16:01+11:00 https://pharmadispatch.com/news/key-pharmaceuticals-builds-on-40-year-legacy-to-support-frontline-health 2025-10-16T01:30:01+11:00 https://pharmadispatch.com/news/ndis-participant-numbers-and-spending-continue-growth-trajectory-in-latest-quarterly-data 2025-10-16T01:52:01+11:00 https://pharmadispatch.com/news/lillys-oral-glp-1-therapy-delivers-strong-results-in-late-stage-diabetes-trials 2025-10-17T01:08:01+11:00 https://pharmadispatch.com/news/vertex-announces-new-zealand-registration-of-next-generation-cystic-fibrosis-treatment 2025-10-17T01:35:01+11:00 https://pharmadispatch.com/news/new-partnership-aims-to-to-strengthen-local-cell-and-gene-manufacturing-capability 2025-10-17T01:47:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-17-october 2025-10-18T02:28:01+11:00 https://pharmadispatch.com/news/landmark-trial-confirms-survival-benefit-of-lilly-therapy-in-high-risk-early-breast-cancer 2025-10-18T20:56:01+11:00 https://pharmadispatch.com/news/bristol-myers-squibb-becomes-first-global-employer-to-achieve-dual-region-menopause-friendly-acc 2025-10-18T21:07:01+11:00 https://pharmadispatch.com/news/bms-says-september-outcome-could-set-a-new-policy-benchmark-for-access 2025-10-18T23:06:01+11:00 https://pharmadispatch.com/news/an-exceptional-outcome-that-must-not-become-an-exception 2025-10-18T23:37:01+11:00 https://pharmadispatch.com/news/trump-announces-third-mfn-deal-with-a-focus-on-fertility-drug-costs-and-expanding-ivf-access 2025-10-19T00:17:01+11:00 https://pharmadispatch.com/news/advancell-unveils-promising-first-clinical-results-for-212pb-advc001-in-prostate-cancer 2025-10-19T19:28:01+11:00 https://pharmadispatch.com/news/new-combination-therapy-sets-landmark-survival-benchmark-in-bladder-cancer-treatment 2025-10-19T19:48:01+11:00 https://pharmadispatch.com/news/amplia-targets-us-market-expansion-as-fak-inhibitor-shows-promise-in-pancreatic-cancer 2025-10-19T20:08:01+11:00 https://pharmadispatch.com/news/orthocell-boosts-balance-sheet-with-capital-raise-to-drive-nerve-repair-product-growth 2025-10-19T20:24:01+11:00 https://pharmadispatch.com/news/merck-expands-commitment-to-first-nations-stem-leadership-with-new-scholarships-and-partnerships 2025-10-20T06:55:01+11:00 https://pharmadispatch.com/news/australia-records-worst-flu-season-on-record-as-vaccination-rates-stagnate 2025-10-20T18:11:01+11:00 https://pharmadispatch.com/news/patient-centric-partnerships-will-unlock-brighter-and-more-equitable-outcomes-for-all 2025-10-21T14:00:01+11:00 https://pharmadispatch.com/news/pharmac-targets-red-tape-to-streamline-access-to-some-medicines-and-health-consumables 2025-10-20T19:53:01+11:00 https://pharmadispatch.com/news/immutep-unveils-dual-breakthroughs-at-esmo-2025-strengthening-case-for-efti-across-multiple-tumo 2025-10-20T20:13:01+11:00 https://pharmadispatch.com/news/orthocell-expands-stake-in-marine-biomedical-secures-global-rights-to-regenerative-bone-technolo 2025-10-20T20:34:01+11:00 https://pharmadispatch.com/news/algorae-partners-with-cadila-pharmaceuticals-to-launch-therapies-in-australia-and-new-zealand 2025-10-20T20:35:01+11:00 https://pharmadispatch.com/news/biogen-earns-fourth-great-place-to-work-sertification-strengthening-culture-of-inclusion 2025-10-20T21:43:01+11:00 https://pharmadispatch.com/news/neuren-secures-fda-fast-track-designation-for-nnz-2591-in-phelan-mcdermid-syndrome 2025-10-20T21:50:01+11:00 https://pharmadispatch.com/news/radiopharm-secures-funding-to-accelerate-radiopharmaceutical-pipeline-as-data-show-strong-moment 2025-10-20T21:52:01+11:00 https://pharmadispatch.com/news/monash-scientists-crack-genetic-code-behind-rna-splicing-opening-door-to-to-new-therapies 2025-10-20T21:53:01+11:00 https://pharmadispatch.com/news/nzs-pharmac-proposes-new-rules-to-manage-options-for-investment-list 2025-10-20T22:01:01+11:00 https://pharmadispatch.com/news/vaccine-confidence-slips-as-australians-grow-more-concerned-about-access-to-healthcare 2025-10-20T22:15:01+11:00 https://pharmadispatch.com/news/endometriosis-diagnoses-in-australian-gp-clinics-nearly-double-over-a-decade 2025-10-21T19:51:01+11:00 https://pharmadispatch.com/news/services-australia-reports-record-number-of-processed-pbs-precriptions 2025-10-21T20:17:01+11:00 https://pharmadispatch.com/news/annual-report-confirms-that-companies-repaid-over-16m-in-pbs-benefits-every-day 2025-11-04T13:00:01+11:00 https://pharmadispatch.com/news/astellas-xtandi-achieves-landmark-survival-milestone-in-prostate-cancer 2025-10-21T21:11:01+11:00 https://pharmadispatch.com/news/foi-reforms-setback-transparency-decades-and-will-impact-public-health-decision-making 2025-10-21T21:36:01+11:00 https://pharmadispatch.com/news/idt-australia-sharpens-strategy-with-cost-savings-and-radiopharmaceutical-focus 2025-10-22T05:36:01+11:00 https://pharmadispatch.com/news/the-mirage-of-us-pharmaceutical-pricing-and-how-it-could-obscure-the-impact-of-the-mostfavoredna 2025-10-22T14:00:01+11:00 https://pharmadispatch.com/news/sigma-reports-strong-growth-and-upgraded-synergies-in-first-full-year-post-merger 2025-10-22T21:56:01+11:00 https://pharmadispatch.com/news/sanofi-treatment-for-ultra-rare-asmd-to-be-made-available-through-lsdp 2025-10-22T23:08:01+11:00 https://pharmadispatch.com/news/a-perspective-that-more-accurately-belongs-in-a-time-capsule-from-the-1990s 2025-10-24T06:00:01+11:00 https://pharmadispatch.com/news/gilead-appoints-arthur-miritis-as-new-executive-director-and-general-manager 2025-10-23T20:45:01+11:00 https://pharmadispatch.com/news/michael-azrak-to-depart-moderna-after-four-years-of-leadership 2025-10-23T21:10:01+11:00 https://pharmadispatch.com/news/telix-doses-first-patient-in-solace-trial-for-metastatic-bone-pain 2025-10-23T22:39:01+11:00 https://pharmadispatch.com/news/ausbiotech-invest-kicks-off-australias-biggest-week-in-biotech-innovation 2025-10-23T22:40:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-launches-global-repeat-dose-trial-for-potential-first-in-class-adoa-treatment 2025-10-23T22:41:01+11:00 https://pharmadispatch.com/news/starpharma-receives-upfront-payment-from-genentech-launching-oncology-collaboration 2025-10-23T22:42:01+11:00 https://pharmadispatch.com/news/clarity-pharmaceuticals-copper-theranostics-platform-delivers-superior-prostate-cancer-imaging-r 2025-10-23T22:43:01+11:00 https://pharmadispatch.com/news/impedimed-accelerates-growth-strategy-on-strong-results-and-expanding-market-reach 2025-10-23T22:44:01+11:00 https://pharmadispatch.com/news/4dmedical-secures-stanford-as-first-commercial-site-and-expands-astrazeneca-partnership-in-brazi 2025-10-23T22:45:01+11:00 https://pharmadispatch.com/news/noxopharm-granted-first-us-patent-for-sofra-immune-modulation-platform 2025-10-23T22:45:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-secures-fda-response-date-for-galidesivir-approval-pathway 2025-10-23T22:46:01+11:00 https://pharmadispatch.com/news/new-zealand-identified-as-a-major-outlier-in-oecd-medicines-investment 2025-10-24T11:00:01+11:00 https://pharmadispatch.com/news/omico-appoints-richard-vines-as-new-chair-as-it-strengthens-national-precision-oncology-agenda 2025-10-24T03:16:01+11:00 https://pharmadispatch.com/news/queensland-resources-sector-backs-prevention-first-health-push-to-boost-workforce-productivity 2025-10-24T05:50:01+11:00 https://pharmadispatch.com/news/global-focus-intensifies-as-ausbiotech-strengthens-trade-partnerships-and-international-engageme 2025-10-24T05:58:01+11:00 https://pharmadispatch.com/news/david-henderson-to-lead-takedas-specialty-franchise-in-oceania 2025-10-24T23:16:01+11:00 https://pharmadispatch.com/news/queensland-to-host-ausbiotech-international-conference-and-sector-leadership-strengthened-with-d 2025-10-24T23:23:01+11:00 https://pharmadispatch.com/news/immuron-launches-proibs-in-australia-to-support-people-living-with-ibs 2025-10-24T23:33:01+11:00 https://pharmadispatch.com/news/medicines-australia-hardens-stance-as-us-pressure-sharpens-spotlight-on-pbs-pricing 2025-10-26T20:19:01+11:00 https://pharmadispatch.com/news/mark-butler-announces-the-additon-of-another-contraception-option-to-the-pbs 2025-10-27T19:22:01+11:00 https://pharmadispatch.com/news/cancer-australia-looks-to-accelerate-the-delivery-of-national-plan 2025-10-27T21:18:01+11:00 https://pharmadispatch.com/news/fda-awards-the-first-ever-national-priority-vouchers-to-nine-sponsors 2025-10-27T21:33:01+11:00 https://pharmadispatch.com/news/cann-group-announces-major-debt-restructure-and-capital-raise-to-strengthen-balance-sheet 2025-10-27T22:48:01+11:00 https://pharmadispatch.com/news/leadership-change-at-polynovo-as-long-time-chair-steps-down 2025-10-27T23:47:01+11:00 https://pharmadispatch.com/news/government-backs-new-national-push-to-close-bone-health-testing-gap-for-women 2025-10-28T01:50:01+11:00 https://pharmadispatch.com/news/pyc-reports-strong-clinical-momentum-and-cash-position-ahead-of-key-readouts 2025-10-28T02:24:01+11:00 https://pharmadispatch.com/news/at-least-mfn-is-exposing-the-institutional-mythologies-that-pollute-proper-debate 2025-10-28T20:14:01+11:00 https://pharmadispatch.com/news/australians-with-chronic-kidney-disease-to-benefit-from-new-subsidised-treatment 2025-10-28T22:27:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-backs-expanded-prescribing-rights-for-optometrists 2025-10-28T22:39:01+11:00 https://pharmadispatch.com/news/australians-want-better-access-to-medical-technology-and-a-clearer-pathway-to-get-there 2025-10-28T23:08:01+11:00 https://pharmadispatch.com/news/australians-with-chronic-disease-call-for-stronger-investment-in-pbs 2025-10-29T14:00:01+11:00 https://pharmadispatch.com/news/abbvie-appoints-david-manifold-to-lead-immunology-anz-and-new-zealand-operations 2025-10-29T02:13:01+11:00 https://pharmadispatch.com/news/obviohealth-partners-with-vaxxas-to-advance-needle-free-vaccination-through-digital-clinical-tri 2025-10-29T04:09:01+11:00 https://pharmadispatch.com/news/mtpconnect-signs-cooperation-agreement-with-saudi-ministry-of-health-to-boost-life-sciences-coll 2025-10-29T04:15:01+11:00 https://pharmadispatch.com/news/myrio-therapeutics-partners-with-leading-us-research-institutions-to-advance-t-cell-immunotherap 2025-10-29T04:18:01+11:00 https://pharmadispatch.com/news/australia-launches-first-clinical-and-commercial-scale-viral-vector-manufacturing-facility 2025-10-29T04:46:01+11:00 https://pharmadispatch.com/news/process-as-power-how-our-institutions-defend-policy-decisions-by-making-them-untouchable-truths 2025-10-30T13:00:01+11:00 https://pharmadispatch.com/news/australian-based-world-first-rna-trial-offers-new-hope-for-lupus-patients 2025-10-29T20:24:01+11:00 https://pharmadispatch.com/news/uniseed-names-alastair-hick-as-new-ceo-to-lead-next-phase-of-growth 2025-10-29T20:30:01+11:00 https://pharmadispatch.com/news/rising-obesity-and-youth-vaping-undercut-health-gains-national-index-reveals 2025-10-29T20:50:01+11:00 https://pharmadispatch.com/news/advisoty-committee-backs-avitas-burns-treatment-paving-the-way-for-expanded-access-in-australia 2025-10-29T21:17:01+11:00 https://pharmadispatch.com/news/more-australian-women-to-access-free-gp-led-care-as-evoca-clinics-shift-to-bulk-billing 2025-10-29T21:25:01+11:00 https://pharmadispatch.com/news/duravr-delivers-strong-one-year-results-for-patients-with-small-aortic-annuli 2025-10-29T21:38:01+11:00 https://pharmadispatch.com/news/arovella-advances-ala-101-program-with-cro-appointment-and-phase-1-trial-preparations 2025-10-30T00:14:01+11:00 https://pharmadispatch.com/news/medicines-australia-welcomes-new-directors-and-reaffirms-commitment-to-innovation-and-access 2025-10-30T01:50:01+11:00 https://pharmadispatch.com/news/sl-centenary-fellowships-awarded-to-australian-scientists-pioneering-lifelong-immunity-and-ai-de 2025-10-30T04:35:01+11:00 https://pharmadispatch.com/news/csl-seqirus-partners-to-localise-advanced-influenza-vaccine-manufacturing-in-saudi-arabia 2025-10-30T19:52:01+11:00 https://pharmadispatch.com/news/90-million-investment-marks-30-years-of-the-viertel-foundations-impact-on-medical-research 2025-10-30T20:15:01+11:00 https://pharmadispatch.com/news/fda-moves-to-streamline-biosimilar-development-and-accelerate-approvals 2025-10-30T20:28:01+11:00 https://pharmadispatch.com/news/wintermute-biomedical-appoints-professor-john-skerritt-to-its-board 2025-10-30T20:38:01+11:00 https://pharmadispatch.com/news/the-continued-false-framing-aims-to-make-us-feel-guilty-for-wanting-more-on-health 2025-10-31T14:00:01+11:00 https://pharmadispatch.com/news/new-report-warns-of-rising-copd-crisis-as-deaths-outnumber-other-major-conditions 2025-10-31T13:00:01+11:00 https://pharmadispatch.com/news/honouring-a-mothers-memory-az-executives-ride-for-metastatic-breast-cancer-patients 2025-10-31T01:22:01+11:00 https://pharmadispatch.com/news/viral-vector-manufacturing-facility-partners-with-oxb-to-advance-gene-therapy-capability-in-aust 2025-10-31T02:47:01+11:00 https://pharmadispatch.com/news/patients-and-providers-unite-to-shape-national-telehealth-standards 2025-10-31T05:26:01+11:00 https://pharmadispatch.com/news/dhl-supply-chain-opens-new-zealands-most-advanced-life-sciences-and-healthcare-logistics-facilit 2025-10-31T19:56:01+11:00 https://pharmadispatch.com/news/amplia-therapeutics-begins-trading-on-us-otcqb-venture-market 2025-10-31T20:40:01+11:00 https://pharmadispatch.com/news/firebrick-pharma-launches-new-nasodine-throat-spray-for-international-markets 2025-10-31T20:45:01+11:00 https://pharmadispatch.com/news/immuron-provides-update-on-us-clinical-trials-for-travelan-and-imm-529 2025-10-31T20:50:01+11:00 https://pharmadispatch.com/news/expanded-pbsaccess-fortherapy-to-includefirst-line-epilepsy-treatment 2025-11-03T13:00:01+11:00 https://pharmadispatch.com/news/aroa-biosurgery-appoints-paul-shearer-to-board-as-john-pinion-retires 2025-10-31T22:09:01+11:00 https://pharmadispatch.com/news/global-biosimilars-week-2025-launches-with-focus-on-advancing-health-equity-through-access-and-i 2025-11-03T13:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-31-october 2025-10-31T23:43:01+11:00 https://pharmadispatch.com/news/a-new-treatment-for-rare-liver-disease-now-listed-on-the-pbs 2025-11-01T04:19:01+11:00 https://pharmadispatch.com/news/new-dual-immunotherapy-option-for-advanced-liver-cancer-listed-on-the-pbs 2025-11-01T19:33:01+11:00 https://pharmadispatch.com/news/pfizer-escalates-planned-takeover-of-metsera-after-novo-nordisk-enters-the-fray 2025-11-01T20:17:01+11:00 https://pharmadispatch.com/news/msac-rejects-calls-to-expand-access-to-continuous-glucose-monitoring-devices 2025-11-01T21:04:01+11:00 https://pharmadispatch.com/news/if-they-keep-ignoring-patient-input-or-worse-inventing-their-own-stop-asking-for-it 2025-11-04T13:00:01+11:00 https://pharmadispatch.com/news/new-pbs-listing-expands-frontline-options-for-australians-with-advanced-hodgkin-lymphoma 2025-11-03T13:58:01+11:00 https://pharmadispatch.com/news/actinogen-medical-presents-alzheimers-and-depression-program-at-bio-europe-2025 2025-11-03T20:15:01+11:00 https://pharmadispatch.com/news/fda-approves-anteris-technologies-global-pivotal-trial-for-duravr-heart-valve 2025-11-03T20:30:01+11:00 https://pharmadispatch.com/news/orthocell-expands-asian-presence-with-first-remplir-surgical-case-in-hong-kong 2025-11-03T20:41:01+11:00 https://pharmadispatch.com/news/pharmac-marks-milestone-in-change-program-with-completion-of-first-90-day-plan 2025-11-03T21:43:01+11:00 https://pharmadispatch.com/news/resmed-delivers-strong-start-to-year-with-double-digit-profit-growth-and-margin-expansion 2025-11-03T22:47:01+11:00 https://pharmadispatch.com/news/eight-finalists-announced-for-inaugural-marie-krogh-young-women-in-science-prize 2025-11-03T23:41:01+11:00 https://pharmadispatch.com/news/new-clinical-trial-offers-hope-for-australians-living-with-vitiligo 2025-11-03T23:50:01+11:00 https://pharmadispatch.com/news/invex-reports-promising-new-data-on-exenatide-in-alzheimers-disease-model 2025-11-04T01:34:01+11:00 https://pharmadispatch.com/news/dr-andre-bates-on-pharmas-real-ai-challenge-if-the-technology-is-ready-why-isnt-the-culture 2025-11-04T20:48:01+11:00 https://pharmadispatch.com/news/pfizer-escalates-legal-fight-with-novo-nordisk-over-obesity-biotech-takeover 2025-11-04T20:59:01+11:00 https://pharmadispatch.com/news/rebates-are-bad-enough-without-invoices-based-on-unconstitutional-pbs-benefit-claims 2025-11-05T00:47:01+11:00 https://pharmadispatch.com/news/trent-twomey-appointed-president-of-the-world-pharmacy-council 2025-11-05T01:13:01+11:00 https://pharmadispatch.com/news/national-vaccine-and-infectious-disease-incubator-to-launch-in-november 2025-11-05T03:13:01+11:00 https://pharmadispatch.com/news/sandoz-launches-pbs-listed-adhd-medicine-to-help-ease-national-supply-shortages 2025-11-05T03:27:01+11:00 https://pharmadispatch.com/news/radium-capital-surpasses-1-billion-milestone-in-innovation-funding 2025-11-05T19:45:01+11:00 https://pharmadispatch.com/news/orthocell-expands-canadian-presence-with-full-national-coverage-for-nerve-repair-device 2025-11-05T20:20:01+11:00 https://pharmadispatch.com/news/noxopharm-advances-autoimmune-drug-trial-as-heracles-enters-second-phase 2025-11-05T20:25:01+11:00 https://pharmadispatch.com/news/imagion-biosystems-reports-positive-results-from-wayne-state-collaboration-as-phase-2-breast-can 2025-11-05T20:54:01+11:00 https://pharmadispatch.com/news/nanosonics-announces-20-million-share-buy-back-as-confidence-in-growth-outlook-strengthens 2025-11-05T20:59:01+11:00 https://pharmadispatch.com/news/hong-kong-positions-itself-as-a-global-bridge-for-biotech-and-life-sciences-innovation 2025-11-05T21:30:01+11:00 https://pharmadispatch.com/news/mesoblast-to-meet-with-us-fda-over-potential-non-opioid-treatment-for-chronic-back-pain 2025-11-05T21:52:01+11:00 https://pharmadispatch.com/news/ndis-growth-begins-to-slow-but-spending-still-tops-46-billion 2025-11-05T22:36:01+11:00 https://pharmadispatch.com/news/medibank-expands-primary-care-footprint-with-major-acquisition-of-better-medical 2025-11-05T22:54:01+11:00 https://pharmadispatch.com/news/rhythm-biosciences-appoints-gavin-fox-smith-as-chair 2025-11-06T00:39:01+11:00 https://pharmadispatch.com/news/bionsw-opens-expressions-of-interest-for-november-bioinvest-catalyst-event 2025-11-06T01:44:01+11:00 https://pharmadispatch.com/news/pharmacy-leaders-tour-npsas-brisbane-medicine-distribution-centre 2025-11-06T02:34:01+11:00 https://pharmadispatch.com/news/linda-burney-to-chair-new-first-nations-pharmacy-network 2025-11-06T03:09:01+11:00 https://pharmadispatch.com/news/what-next-for-pbs-rebate-system-amid-constitutional-breaches-disputed-claims-and-global-pressure 2025-11-06T20:06:01+11:00 https://pharmadispatch.com/news/pfizer-to-continue-legal-fight-as-court-rejects-bid-to-block-novo-nordisks-metsera-takeover-bid 2025-11-06T20:55:01+11:00 https://pharmadispatch.com/news/us-ambassador-warns-uk-risks-losing-pharma-investment-unless-it-pays-more-for-medicines 2025-11-06T21:23:01+11:00 https://pharmadispatch.com/news/neuren-posts-record-royalties-as-daybue-sales-surpass-us100-million-in-third-quarter 2025-11-06T21:50:01+11:00 https://pharmadispatch.com/news/sanofi-employees-contribute-over-400-volunteer-hours-to-community-and-environmental-causes 2025-11-07T04:18:01+11:00 https://pharmadispatch.com/news/trump-announces-mfn-deal-with-lilly-and-novo-nordisk-and-end-to-global-freeloading 2025-11-07T15:31:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-7-november 2025-11-08T01:45:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-you-cant-fragment-care-youre-not-receiving 2025-11-08T21:15:01+11:00 https://pharmadispatch.com/news/experts-call-for-national-action-to-lift-maternal-and-adult-immunisation-as-whooping-cough-epide 2025-11-09T12:00:01+11:00 https://pharmadispatch.com/news/australia-excluded-from-us-generous-benchmarking-model-that-pegs-prices-to-group-of-eight 2025-11-10T12:00:01+11:00 https://pharmadispatch.com/news/from-potential-to-practice-ai-health-summit-to-focus-on-adoption-implementation-and-governance 2025-11-09T20:18:01+11:00 https://pharmadispatch.com/news/avita-medical-narrows-losses-and-secures-eu-approval-as-reimbursement-challenges-ease 2025-11-09T21:21:01+11:00 https://pharmadispatch.com/news/proteomics-international-secures-wa-government-grant-to-advance-world-first-blood-test-for-endom 2025-11-09T21:26:01+11:00 https://pharmadispatch.com/news/monash-leads-world-first-trial-of-cholesterol-lowering-gene-editing-therapy 2025-11-10T18:20:01+11:00 https://pharmadispatch.com/news/vaxxas-appoints-global-vaccine-leader-to-board-as-needle-free-vaccine-patch-moves-toward-market 2025-11-11T04:43:01+11:00 https://pharmadispatch.com/news/pfizer-clinches-metsera-reshaping-the-balance-in-the-global-obesity-drug-race 2025-11-11T15:16:01+11:00 https://pharmadispatch.com/news/ai-must-be-trusted-transparent-and-integrated-in-the-future-of-health-technology-assessment 2025-11-11T23:44:01+11:00 https://pharmadispatch.com/news/hta-review-implementation-group-is-is-recommending-a-defining-role-for-ai 2025-11-12T00:59:01+11:00 https://pharmadispatch.com/news/professor-robyn-ward-ai-wont-replace-us-but-it-will-redefine-how-we-work 2025-11-12T01:25:01+11:00 https://pharmadispatch.com/news/csl-welcomes-msac-support-for-gene-therapy-but-questions-strict-cost-neutrality-framework 2025-11-12T02:14:01+11:00 https://pharmadispatch.com/news/noxopharm-and-unsw-collaborate-on-gene-based-approach-to-reducing-implant-inflammation 2025-11-12T02:49:01+11:00 https://pharmadispatch.com/news/neuroscientific-advances-stemsmart-therapy-with-fourth-patient-treated-in-crohns-disease-program 2025-11-12T02:50:01+11:00 https://pharmadispatch.com/news/monash-engineers-develop-first-tailored-heart-pump-for-under-treated-heart-failure-patients 2025-11-12T02:51:01+11:00 https://pharmadispatch.com/news/pathkeyai-and-armstrong-clinical-partner-to-strengthen-early-phase-trial-success-through-ai 2025-11-12T21:40:01+11:00 https://pharmadispatch.com/news/australians-open-to-ai-in-healthcare-but-prefer-doctors-to-be-in-control 2025-11-13T12:00:01+11:00 https://pharmadispatch.com/news/microba-renews-board-with-new-appointment-as-long-serving-directors-retire 2025-11-12T22:10:01+11:00 https://pharmadispatch.com/news/dorsavi-secures-breakthrough-neuromorphic-technology-to-power-next-generation-wearables-and-robo 2025-11-12T22:16:01+11:00 https://pharmadispatch.com/news/arovella-appoints-former-csl-chief-scientific-officer-dr-andrew-nash-to-its-board 2025-11-12T22:33:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-advances-phase-1-trial-of-177lu-rad204-in-pd-l1-positive-cancers 2025-11-12T22:42:01+11:00 https://pharmadispatch.com/news/optometry-australia-and-alcon-launch-scholarship-fund-to-support-first-nations-eye-health-leader 2025-11-12T23:11:01+11:00 https://pharmadispatch.com/news/fda-moves-to-lift-long-standing-hormone-therapy-warnings-in-major-shift-for-womens-health 2025-11-12T23:18:01+11:00 https://pharmadispatch.com/news/new-zealand-accelerates-medicines-reform-with-major-regulatory-changes 2025-11-12T23:25:01+11:00 https://pharmadispatch.com/news/every-government-agency-to-get-a 2025-11-13T04:26:01+11:00 https://pharmadispatch.com/news/nanosonics-names-new-north-american-president-ahead-of-coris-launch 2025-11-13T20:38:01+11:00 https://pharmadispatch.com/news/rage-biotech-raises-29-million-and-appoints-new-leadership-to-advance-precision-rna-therapeutics 2025-11-13T20:42:01+11:00 https://pharmadispatch.com/news/sanofi-building-an-ai-literate-organisation-through-expectations-over-experiments 2025-11-14T12:00:01+11:00 https://pharmadispatch.com/news/government-adds-new-first-line-treatment-to-the-pbs-for-deadly-blood-cancer 2025-11-13T21:49:01+11:00 https://pharmadispatch.com/news/new-post-market-review-workplan-focuses-on-real-world-data-and-patient-outcomes 2025-11-13T21:59:01+11:00 https://pharmadispatch.com/news/australia-joins-global-who-task-force-to-tackle-antimicrobial-resistance 2025-11-13T22:10:01+11:00 https://pharmadispatch.com/news/prospection-says-data-access-and-leadership-are-critical-to-unlock-ais-potential-in-healthcare 2025-11-14T12:00:01+11:00 https://pharmadispatch.com/news/the-four-h-words-that-can-help-drive-the-adoption-of-ai-in-health 2025-11-14T12:00:01+11:00 https://pharmadispatch.com/news/chimeric-therapeutics-reports-strong-early-results-from-chm-cdh17-phase-12-trial 2025-11-13T22:51:01+11:00 https://pharmadispatch.com/news/new-gene-discoveries-improve-diagnosis-of-inherited-heart-disease 2025-11-14T01:24:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-appoints-peter-coleman-as-new-chair-as-part-of-board-renewal 2025-11-14T02:25:01+11:00 https://pharmadispatch.com/news/immutep-posts-encouraging-phase-2-results-as-efti-spurs-robust-anti-tumour-activity 2025-11-14T02:37:01+11:00 https://pharmadispatch.com/news/arrotex-launches-new-pbs-listed-combination-therapy-as-gap-emerges-in-hypertension-treatments 2025-11-14T12:00:01+11:00 https://pharmadispatch.com/news/pyc-reports-sustained-vision-gains-in-rp11-clinical-trial 2025-11-15T20:28:01+11:00 https://pharmadispatch.com/news/recce-pharmaceuticals-pays-tribute-to-founder-and-scientific-pioneer-dr-graham-melrose 2025-11-15T20:44:01+11:00 https://pharmadispatch.com/news/biotron-reports-promising-advances-in-hepatitis-b-program-as-lead-candidate-shows-strong-antivir 2025-11-15T20:52:01+11:00 https://pharmadispatch.com/news/new-national-incubator-aims-to-supercharge-australian-vaccine-innovation 2025-11-17T13:00:01+11:00 https://pharmadispatch.com/news/msd-to-acquire-cidara-therapeutics-adding-long-acting-influenza-antiviral-cd388-to-its-pipeline 2025-11-15T21:30:01+11:00 https://pharmadispatch.com/news/time-to-save-the-government-from-itself-and-its-own-bad-habits-on-this-program 2025-11-17T13:00:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-reaches-enrollment-milestone-in-phase-2b-trial-for-rad101 2025-11-17T19:59:01+11:00 https://pharmadispatch.com/news/noxopharm-begins-daily-dosing-in-second-phase-of-heracles-trial 2025-11-17T20:04:01+11:00 https://pharmadispatch.com/news/we-know-theyre-planning-something-on-these-issues-because-they-told-us 2025-11-18T12:00:01+11:00 https://pharmadispatch.com/news/race-oncology-launches-new-clinical-programs-in-aml-and-lung-cancer 2025-11-17T20:36:01+11:00 https://pharmadispatch.com/news/argent-biopharma-secures-significant-financing-facility-to-support-strategic-expansion 2025-11-17T21:06:01+11:00 https://pharmadispatch.com/news/mesoblast-appoints-new-chief-financial-officer-as-it-evolves-into-fully-integrated-commercial-or 2025-11-17T21:16:01+11:00 https://pharmadispatch.com/news/syntara-secures-positive-european-opinion-for-orphan-designation-of-amsulostat-in-myelofibrosis 2025-11-17T21:31:01+11:00 https://pharmadispatch.com/news/bms-australia-team-cycles-across-japan-raising-nearly-20000-for-bowel-cancer-australia 2025-11-18T00:35:01+11:00 https://pharmadispatch.com/news/the-need-to-honour-a-strong-history-while-ensuring-the-future-is-guided-by-the-good-guys 2025-11-18T00:56:01+11:00 https://pharmadispatch.com/news/is-this-disconnect-so-entrenched-we-can-no-longer-recognise-the-presence-of-a-problem 2025-11-19T12:00:01+11:00 https://pharmadispatch.com/news/minister-managing-the-double-whammy-of-participant-and-plan-growth 2025-11-19T12:00:01+11:00 https://pharmadispatch.com/news/nyrada-advances-toward-phase-2a-trial-of-cardioprotective-candidate 2025-11-19T00:05:01+11:00 https://pharmadispatch.com/news/tryp-advances-world-first-psilocin-trial-for-binge-eating-disorder-as-second-patient-enrolled 2025-11-19T00:16:01+11:00 https://pharmadispatch.com/news/what-if-the-system-put-people-first-imagining-the-institution-we-dont-have 2025-11-20T12:00:01+11:00 https://pharmadispatch.com/news/bcal-advances-early-cancer-detection-portfolio-as-australian-launch-looms 2025-11-19T20:18:01+11:00 https://pharmadispatch.com/news/prescient-secures-eu-orphan-status-for-ptx-100-for-cutaneous-t-cell-lymphomas 2025-11-19T20:58:01+11:00 https://pharmadispatch.com/news/dimerix-phase-3-kidney-trial-clears-seventh-safety-review 2025-11-19T21:12:01+11:00 https://pharmadispatch.com/news/idt-australia-resets-strategy-as-advanced-therapies-drive-new-phase-of-growth 2025-11-19T21:20:01+11:00 https://pharmadispatch.com/news/cleo-diagnostics-appoints-us-oncologist-as-first-key-opinion-leader 2025-11-19T21:33:01+11:00 https://pharmadispatch.com/news/csl-unveils-us-expansion-cementing-its-position-as-a-global-biopharma-leader 2025-11-19T21:52:01+11:00 https://pharmadispatch.com/news/oncosil-charts-a-new-growth-phase-as-chairman-outlines-progress-and-opportunities 2025-11-19T22:37:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-appoints-experienced-industry-executive-to-its-board 2025-11-20T00:14:01+11:00 https://pharmadispatch.com/news/march-pbac-agenda-confirms-a-diverse-range-of-therapies-up-for-consideration 2025-11-20T01:29:01+11:00 https://pharmadispatch.com/news/vertex-ssecures-tga-approval-for-next-generation-cystic-fibrosis-therapy 2025-11-20T05:44:01+11:00 https://pharmadispatch.com/news/ronak-patel-appointed-to-lead-alcons-commercial-management-for-vision-care 2025-11-20T16:03:01+11:00 https://pharmadispatch.com/news/if-the-system-properly-applied-results-in-harm-then-surely-surely-we-have-a-huge-problem 2025-11-21T06:00:01+11:00 https://pharmadispatch.com/news/aft-pharmaceuticals-posts-record-first-half-revenue-as-international-strategy-accelerates 2025-11-20T21:18:01+11:00 https://pharmadispatch.com/news/amplia-secures-positive-fda-feedback-clearing-path-toward-late-2026-registration-trial 2025-11-20T21:25:01+11:00 https://pharmadispatch.com/news/new-analysis-shows-telixs-tlx250-cdx-could-change-management-of-renal-masses 2025-11-21T01:35:01+11:00 https://pharmadispatch.com/news/silence-in-response-to-unethical-processes-and-outcomes-is-itself-unethical 2025-11-21T03:57:01+11:00 https://pharmadispatch.com/news/treasurer-blocks-us-takeover-of-mayne-pharma-on-national-interest-grounds 2025-11-22T20:23:01+11:00 https://pharmadispatch.com/news/alterity-therapeutics-chairman-reflects-on-two-decades-of-progress-as-company-enters-new-era 2025-11-22T20:35:01+11:00 https://pharmadispatch.com/news/syntara-launches-phase-2-trial-aiming-to-teduce-transfusion-burden-in-myelodysplastic-syndromes 2025-11-22T20:44:01+11:00 https://pharmadispatch.com/news/mesoblast-to-launch-pivotal-adult-trial-for-cell-therapy-in-severe-steroid-refractory-gvhd 2025-11-22T20:53:01+11:00 https://pharmadispatch.com/news/australian-melanoma-oncologist-awarded-inaugural-marie-krogh-prize-for-young-women-in-science 2025-11-26T14:00:01+11:00 https://pharmadispatch.com/news/new-national-scorecard-reveals-australia-is-still-ignoring-its-deadliest-and-most-costly-cancer 2025-11-26T14:00:01+11:00 https://pharmadispatch.com/news/new-trojan-horse-treatment-offers-hope-for-australians-facing-relapsed-multiple-myeloma 2025-11-24T14:00:01+11:00 https://pharmadispatch.com/news/new-national-report-warns-of-deepening-ovarian-cancer-burden-and-calls-for-urgent-action 2025-11-24T14:00:01+11:00 https://pharmadispatch.com/news/a-scrapped-websits-almost-100-million-and-the-politics-of-what-really-matters 2025-11-24T01:52:01+11:00 https://pharmadispatch.com/news/moderna-names-csiro-scientist-dr-anne-klein-as-2025-australian-fellow 2025-11-24T19:57:01+11:00 https://pharmadispatch.com/news/sanofi-becomes-first-tenant-of-entri-marking-major-step-for-queenslands-translational-research-a 2025-11-24T20:04:01+11:00 https://pharmadispatch.com/news/new-paper-recommends-a-balanced-and-measure-approach-to-adopting-ai-in-clinical-practice 2025-11-24T20:47:01+11:00 https://pharmadispatch.com/news/cynata-completes-final-patient-visits-in-pivotal-phase-3-osteoarthritis-trial 2025-11-24T20:58:01+11:00 https://pharmadispatch.com/news/nsw-premier-opens-australias-first-large-scale-health-translation-hub-at-unsw 2025-11-25T00:04:01+11:00 https://pharmadispatch.com/news/australia-has-all-the-ingredients-but-has-to-decide-what-kind-of-health-system-it-wants 2025-11-26T14:00:01+11:00 https://pharmadispatch.com/news/national-report-calls-for-screening-as-25000-australians-live-with-early-disease-without-knowing 2025-11-26T13:00:01+11:00 https://pharmadispatch.com/news/argenica-validates-optimal-dose-of-arg-007-in-independent-preclinical-stroke-study 2025-11-25T20:38:01+11:00 https://pharmadispatch.com/news/new-asthma-guidelines-warn-against-blue-puffer-only-treatment-as-deaths-remain-stubbornly-high 2025-11-26T14:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-appoints-anthea-stephenson-to-lead-national-industry-growth-program 2025-11-26T04:13:01+11:00 https://pharmadispatch.com/news/new-report-shows-precision-approach-extends-lives-but-many-still-missing-out 2025-11-26T05:13:01+11:00 https://pharmadispatch.com/news/an-interview-that-reminds-us-of-the-missing-discussion-in-australia 2025-11-27T13:00:01+11:00 https://pharmadispatch.com/news/adalta-chair-says-the-company-is-on-the-cusp-of-transformational-growth 2025-11-26T20:04:01+11:00 https://pharmadispatch.com/news/syntara-advances-next-generation-anti-fibrotic-cream-into-phase-1b-trial 2025-11-26T20:31:01+11:00 https://pharmadispatch.com/news/race-oncology-secures-human-ethics-approval-for-lung-cancer-trial-of-rc220 2025-11-26T20:57:01+11:00 https://pharmadispatch.com/news/recce-reports-strong-preclinical-efficacy-for-inhaled-r327-in-hospital-acquired-pneumonia-model 2025-11-26T21:12:01+11:00 https://pharmadispatch.com/news/us-medicare-sets-reimbursement-price-for-promarkerd-paving-way-for-major-commercial-rollout 2025-11-26T21:25:01+11:00 https://pharmadispatch.com/news/the-us-and-uk-edging-close-to-an-agreement-on-pharmaceutical-pricing 2025-11-26T21:37:01+11:00 https://pharmadispatch.com/news/us-secures-significant-price-reductions-on-15-medicines-in-second-round-of-medicare-negotiations 2025-11-26T21:59:01+11:00 https://pharmadispatch.com/news/slade-pharmacy-marks-anniversary-with-record-research-contributions-at-conferences 2025-11-26T22:17:01+11:00 https://pharmadispatch.com/news/neurizon-therapeutics-entering-a-promising-new-horizon-as-als-program-advances 2025-11-27T02:12:01+11:00 https://pharmadispatch.com/news/algorae-pharmaceuticals-secures-new-supply-of-chemotherapy-for-australia-through-dr-reddys-partn 2025-11-27T20:24:01+11:00 https://pharmadispatch.com/news/imugene-and-jw-therapeutics-join-forces-on-first-in-class-combination-for-solid-tumours 2025-11-27T20:32:01+11:00 https://pharmadispatch.com/news/australia-releases-first-national-estimate-of-women-living-with-metastatic-breast-cancer 2025-11-27T21:05:01+11:00 https://pharmadispatch.com/news/landmark-report-warns-australias-hospital-pharmacy-system-is-at-an-inflection-point 2025-11-27T21:24:01+11:00 https://pharmadispatch.com/news/pharmac-announces-90-day-dispensed-quantities-hiv-medicines 2025-11-28T00:16:01+11:00 https://pharmadispatch.com/news/msd-to-bring-vaccine-distribution-back-in-house-after-40-year-partnership 2025-12-01T13:00:01+11:00 https://pharmadispatch.com/news/five-australians-honoured-for-leadership-and-community-advocacy-in-evolving-hiv-response 2025-12-01T12:00:01+11:00 https://pharmadispatch.com/news/new-pbs-listing-offers-fresh-hope-for-australians-living-with-debilitating-skin-condition 2025-12-01T12:19:01+11:00 https://pharmadispatch.com/news/chimeric-signals-board-refresh-and-shareholder-support-as-lead-trial-advances 2025-11-30T21:33:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-30-november 2025-12-01T00:17:01+11:00 https://pharmadispatch.com/news/budget-discipline-tightens-as-agencies-directed-to-target-lowest-priority-work 2025-12-01T01:27:01+11:00 https://pharmadispatch.com/news/tetratherix-joint-venture-secures-alcon-partnership-to-accelerate-ophthalmic-biomaterials 2025-12-01T23:19:01+11:00 https://pharmadispatch.com/news/pharmac-to-expand-emergency-medicine-access-for-rural-and-remote-communities 2025-12-01T23:35:01+11:00 https://pharmadispatch.com/news/melbourne-showcases-its-health-and-biomedical-strength-as-leaders-gather-for-national-precincts- 2025-12-02T00:33:01+11:00 https://pharmadispatch.com/news/australian-company-reports-high-response-rate-in-trial-of-off-the-shelf-car-t-therapy 2025-12-02T02:27:01+11:00 https://pharmadispatch.com/news/dbg-health-appoints-matt-zeller-to-lead-arrotex-pharmaceuticals-into-its-next-phase-of-growth 2025-12-02T03:23:01+11:00 https://pharmadispatch.com/news/new-pbs-listing-brings-immunotherapy-option-to-australians-with-rare-head-and-neck-cancer 2025-12-02T03:54:01+11:00 https://pharmadispatch.com/news/novo-nordisk-appoints-michael-azrak-as-new-oceania-general-manager 2025-12-02T04:03:01+11:00 https://pharmadispatch.com/news/cartherics-appoints-dr-ian-nisbet-as-ceo-as-the-company-accelerates-toward-clinical-trials 2025-12-02T05:09:01+11:00 https://pharmadispatch.com/news/us-and-uk-strike-landmark-pharmaceutical-pricing-deal-lifting-prices 2025-12-02T13:05:01+11:00 https://pharmadispatch.com/news/cost-of-multiple-sclerosis-in-australia-surges-past-3-billion-as-prevalence-accelerates 2025-12-03T13:00:01+11:00 https://pharmadispatch.com/news/new-national-push-to-close-australias-cardiovascular-data-gap 2025-12-02T20:01:01+11:00 https://pharmadispatch.com/news/australia-can-just-increase-prices-in-response-to-pressure-as-it-did-three-years-ago-for-950-med 2025-12-03T00:30:01+11:00 https://pharmadispatch.com/news/immutep-unveils-strong-phase-2-data-ahead-of-san-antonio-breast-cancer-symposium 2025-12-02T20:55:01+11:00 https://pharmadispatch.com/news/first-patient-successfully-dosed-in-trp-8803-trial-to-treat-binge-eating-disorder 2025-12-02T21:01:01+11:00 https://pharmadispatch.com/news/burnt-out-australians-rush-to-health-appointments-as-year-end-pressure-peaks 2025-12-02T22:15:01+11:00 https://pharmadispatch.com/news/clinuvel-advances-second-therapy-toward-market-with-planned-2026-european-filing 2025-12-02T23:22:01+11:00 https://pharmadispatch.com/news/seqirus-ipens-world-class-cell-based-vaccine-and-antivenom-manufacturing-facility 2025-12-02T23:24:01+11:00 https://pharmadispatch.com/news/novo-nordisk-raises-over-106000-for-type-1-diabetes-research 2025-12-02T23:31:01+11:00 https://pharmadispatch.com/news/reforming-australias-opioid-dependence-treatment-program-from-red-tape-to-person-centred-care 2025-12-03T00:17:01+11:00 https://pharmadispatch.com/news/noxopharm-advances-autoimmune-candidate-as-first-multiple-dose-cohort-clears-safety-review 2025-12-03T20:04:01+11:00 https://pharmadispatch.com/news/bcal-launches-national-registry-to-track-real-world-impact-of-breastestplus 2025-12-03T20:10:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-secures-boost-as-directors-and-major-shareholders-exercise-options 2025-12-03T20:13:01+11:00 https://pharmadispatch.com/news/melbourne-scientists-discover-how-electrical-pulses-could-transform-tissue-and-organ-regeneratio 2025-12-03T20:18:01+11:00 https://pharmadispatch.com/news/ceo-pay-rebounds-across-asx-health-and-biotech-as-boards-balance-pressure-and-retention 2025-12-03T21:23:01+11:00 https://pharmadispatch.com/news/medtech-pipeline-accelerates-as-report-showcases-translation-success-of-mtpconnect-backed-innova 2025-12-03T21:26:01+11:00 https://pharmadispatch.com/news/new-reports-highlights-challenges-facing-australias-rare-disease-patients 2025-12-03T21:35:01+11:00 https://pharmadispatch.com/news/tight-budget-settings-raise-the-stakes-for-hta-reform-and-pbs-price-negotiations 2025-12-03T21:49:01+11:00 https://pharmadispatch.com/news/ai-driven-health-performance-platform-launches-in-australia 2025-12-04T02:47:01+11:00 https://pharmadispatch.com/news/ltr-pharma-advances-spontan-program-with-ethics-approval-for-phase-2-clinical-trial 2025-12-04T02:57:01+11:00 https://pharmadispatch.com/news/saying-the-quiet-part-out-loud-in-what-one-exchange-reveals-about-the-truth-of-the-pbs 2025-12-04T21:03:01+11:00 https://pharmadispatch.com/news/government-funds-a-first-of-its-kind-twice-yearly-injectable-for-multiple-sclerosis 2025-12-04T21:57:01+11:00 https://pharmadispatch.com/news/health-department-defends-its-handling-of-mfn-risk-amid-senate-scrutiny 2025-12-04T23:20:01+11:00 https://pharmadispatch.com/news/new-report-warns-of-sharp-rise-in-multiple-sclerosis-as-merck-urges-greater-investment 2025-12-04T23:31:01+11:00 https://pharmadispatch.com/news/evinco-therapeutics-launches-to-pioneer-immune-based-treatments-for-alzheimers-disease 2025-12-05T02:25:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-5-december 2025-12-06T00:33:01+11:00 https://pharmadispatch.com/news/either-deliberately-misleading-or-did-not-have-the-correct-information 2025-12-06T05:28:01+11:00 https://pharmadispatch.com/news/new-digital-insights-reveal-what-australians-really-want-from-health-conversations 2025-12-08T13:00:01+11:00 https://pharmadispatch.com/news/daiichi-sankyo-ceo-sets-ambitious-global-oncology-vision-as-company-enters-new-era-of-innovation 2025-12-08T13:00:01+11:00 https://pharmadispatch.com/news/pbacs-intracycle-agenda-dominated-by-internal-submissions-as-msd-pushes-for-multi-cancer-funding 2025-12-07T20:25:01+11:00 https://pharmadispatch.com/news/algorae-pharmaceuticals-achieves-milestone-with-validation-of-ai-drug-combination-platform 2025-12-07T21:14:01+11:00 https://pharmadispatch.com/news/pfizer-unveils-phase-3-results-showing-hympavzi-significantly-reduces-bleeding-in-haemophilia 2025-12-07T21:31:01+11:00 https://pharmadispatch.com/news/csls-hemophilia-therapy-shows-durable-five-year-benefits-in-landmark-trial-results 2025-12-09T13:00:01+11:00 https://pharmadispatch.com/news/australia-at-a-turning-point-on-access-to-medical-technology-new-report-warns 2025-12-09T13:00:01+11:00 https://pharmadispatch.com/news/psa-ushers-in-new-leadership-team-as-organisation-enters-growth-phase 2025-12-08T23:14:01+11:00 https://pharmadispatch.com/news/chimeric-secures-key-orphan-drug-designation-paving-the-way-for-accelerated-development 2025-12-09T02:00:01+11:00 https://pharmadispatch.com/news/imugene-secures-fda-support-for-azer-cel-registrational-pathway 2025-12-09T02:00:01+11:00 https://pharmadispatch.com/news/telix-doses-first-patient-in-expanded-phase-3-prostate-cancer-trial 2025-12-09T02:03:01+11:00 https://pharmadispatch.com/news/australias-imperfect-processes-for-for-sovereign-vaccine-manufacturing-anao-finds 2025-12-09T02:54:01+11:00 https://pharmadispatch.com/news/arrotex-launches-australias-first-generic-fluticasone-nasal-spray 2025-12-09T03:20:01+11:00 https://pharmadispatch.com/news/australian-breakthrough-uncovers-genetic-trigger-for-severe-macular-degeneration 2025-12-09T19:36:01+11:00 https://pharmadispatch.com/news/australian-regulators-approve-longevity-molecule-nmn-for-use-in-therapeutic-goods 2025-12-09T19:37:01+11:00 https://pharmadispatch.com/news/health-department-clarifies-pbac-plan-after-confusion-over-paediatric-access-to-biologics 2025-12-10T14:00:01+11:00 https://pharmadispatch.com/news/if-this-was-the-plan-why-wasnt-it-included-in-the-response-to-questions-last-week 2025-12-10T13:00:01+11:00 https://pharmadispatch.com/news/immutep-strikes-major-licensing-deal-with-dr-reddys-to-commercialise-novel-cancer-immunotherapy 2025-12-10T02:06:01+11:00 https://pharmadispatch.com/news/pfizers-high-stakes-sprint-to-build-momentum-in-century-defining-market 2025-12-11T13:10:01+11:00 https://pharmadispatch.com/news/oncosil-announces-first-uk-patient-treated-with-its-pancreatic-cancer-treatment 2025-12-10T21:24:01+11:00 https://pharmadispatch.com/news/tga-clears-the-way-for-ltr-pharmas-phase-2-study-of-spontan 2025-12-10T21:28:01+11:00 https://pharmadispatch.com/news/mayne-pharma-rejects-cosettes-attempt-to-terminate-scheme-deal 2025-12-10T21:35:01+11:00 https://pharmadispatch.com/news/opportunity-cost-is-a-moral-and-ethical-question-when-it-involves-travel-tickets-or-treating-sic 2025-12-11T21:45:01+11:00 https://pharmadispatch.com/news/bms-marks-70-years-in-australia-with-renewed-commitment-to-innovation-and-access 2025-12-12T03:12:01+11:00 https://pharmadispatch.com/news/medicines-australia-gains-a-new-voice-with-vertex-joining-the-association 2025-12-12T03:28:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-12-december 2025-12-12T21:48:01+11:00 https://pharmadispatch.com/news/the-lesson-to-learn-from-the-guild-ia-that-you-cannot-defeat-what-you-do-not-know 2025-12-15T01:00:01+11:00 https://pharmadispatch.com/news/gbma-to-host-inaugural-summit-aimed-at-addressing-medicine-shortages 2025-12-15T13:00:01+11:00 https://pharmadispatch.com/news/lilly-announces-phase-3-results-for-triple-agonist-in-obesity-and-knee-osteoarthritis 2025-12-15T13:00:01+11:00 https://pharmadispatch.com/news/new-analysis-finds-mesoblasts-remestemcel-l-outperforms-ruxolitinib-in-severe-gvhd 2025-12-14T21:10:01+11:00 https://pharmadispatch.com/news/algorae-unveils-major-breakthrough-in-ai-driven-drug-combination-discovery 2025-12-14T21:17:01+11:00 https://pharmadispatch.com/news/amplia-reports-new-rumour-response-for-narmafotinib-in-pancreatic-cancer 2025-12-14T21:23:01+11:00 https://pharmadispatch.com/news/mtpconnect-opens-applications-for-2026-medtech-procurement-program 2025-12-15T01:06:01+11:00 https://pharmadispatch.com/news/the-industry-is-probably-right-to-resist-it-just-need-to-prepare-for-the-response 2025-12-16T13:00:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-reports-high-success-rate-in-phase-2b-imaging-trial 2025-12-15T21:08:01+11:00 https://pharmadispatch.com/news/dimerix-completes-adult-recruitment-in-phase-3-trial-for-fsgs-treatment-dmx-200 2025-12-15T22:04:01+11:00 https://pharmadispatch.com/news/neuren-wins-second-fda-approval-for-trofinetide-with-launch-of-formulation 2025-12-15T22:09:01+11:00 https://pharmadispatch.com/news/orthocell-lodges-european-and-uk-regulatory-application-for-remplir 2025-12-15T22:12:01+11:00 https://pharmadispatch.com/news/prescient-secures-european-approval-to-launch-ptx-100-trial-for-rare-lymphoma 2025-12-15T22:18:01+11:00 https://pharmadispatch.com/news/cynata-completes-patient-enrolment-in-phase-2-trial-for-agvhd-therapy 2025-12-15T22:23:01+11:00 https://pharmadispatch.com/news/the-uk-confirms-the-direct-impact-of-the-transatlantic-shift-in-medicine-pricing 2025-12-16T22:08:01+11:00 https://pharmadispatch.com/news/budget-update-includes-impact-of-listings-but-generally-not-much-else 2025-12-16T23:25:01+11:00 https://pharmadispatch.com/news/mayne-pharma-opens-expanded-manufacturing-facility-after-termination-of-takeover 2025-12-17T02:56:01+11:00 https://pharmadispatch.com/news/novartis-names-new-country-president-following-leadership-transition 2025-12-17T03:02:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-secures-key-partnership-with-texas-biomed 2025-12-17T20:06:01+11:00 https://pharmadispatch.com/news/budget-update-repeats-the-fiscal-illusion-that-has-become-pbs-spending 2025-12-17T20:57:01+11:00 https://pharmadispatch.com/news/oncosil-completes-first-production-run-at-new-sydney-manufacturing-facility 2025-12-17T21:45:01+11:00 https://pharmadispatch.com/news/antimalarial-candidate-under-wehi-msd-partnership-offers-fresh-hope-against-resistance 2025-12-17T23:56:01+11:00 https://pharmadispatch.com/news/ferronova-secures-funding-to-advance-nanoparticle-technology-for-cancer-surgery 2025-12-18T00:11:01+11:00 https://pharmadispatch.com/news/rare-cancers-australia-gearing-up-for-2026-kosi-challenge-with-pharma-cup-up-for-grabs-again 2025-12-18T02:40:01+11:00 https://pharmadispatch.com/news/priceline-moves-to-stabilise-banner-group-as-pressures-force-administrators 2025-12-18T04:42:01+11:00 https://pharmadispatch.com/news/pbac-reflects-on-a-year-shaped-by-major-reviews-and-rising-workload 2025-12-19T00:22:01+11:00 https://pharmadispatch.com/news/pharmac-scraps-plan-to-remove-low-ranked-medicines-from-options-for-funding-list 2025-12-19T01:16:01+11:00 https://pharmadispatch.com/news/actinogen-crosses-key-milestone-as-pivotal-alzheimers-trial-fully-enrols 2025-12-19T02:43:01+11:00 https://pharmadispatch.com/news/cleo-diagnostics-raises-funds-to-accelerate-us-launch-and-advance-ovarian-cancer-screening 2025-12-19T02:45:01+11:00 https://pharmadispatch.com/news/a-fit-for-purpose-hta-system-will-be-accompanied-by-a-fit-for-system-cost-recovery-framework 2025-12-19T16:11:01+11:00 https://pharmadispatch.com/news/takedas-next-generation-psoriasis-theraph-delivers-landmark-phase-3-results 2025-12-19T22:32:01+11:00 https://pharmadispatch.com/news/pbac-delivers-a-broad-range-of-outcomes-in-november-including-landmark-for-obesity 2025-12-20T23:24:01+11:00 https://pharmadispatch.com/news/parsimony-has-become-an-enduring-test-of-the-institutions-legitimacy 2025-12-20T23:33:01+11:00 https://pharmadispatch.com/news/is-australia-included-in-new-us-international-reference-pricing-rules 2025-12-22T16:58:01+11:00